Back to GetFilings.com
1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
Mark One
X Annual report pursuant to Section 13 or 15(d) of the Securities
- --- Exchange Act of 1934 for the fiscal year ended January 2, 1999.
Transition report pursuant to Section 13 or 15(d) of the Securities
- --- Exchange Act of 1934.
Commission file number 333-56551
EYE CARE CENTERS OF AMERICA, INC.
(Exact name as specified in its charter)
TEXAS 74-2337775
(State or other jurisdiction (IRS employer identification no.)
of incorporation or organization)
11103 West Avenue
San Antonio, Texas 78213-1392
(Address of principal executive offices, including ZIP Code)
(210) 340-3531
(Company's telephone number, including area code)
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT: NONE
SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: NONE
Indicate by check mark whether the Company (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days: Yes No X
--- ---
Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. N/A
---
Aggregate market value of common stock held by non-affiliates of the
registrant is $358,770. As the registrant's common stock is not traded
publicly, the per share price used in this calculation is based on the per share
price of the registrant's last transaction which was the Recapitalization
effective April 24, 1998 ($10.41 per share after stock split).
Applicable only to Corporate Registrants: Indicate the number of shares
outstanding of each of the issuer's classes of common stock as of the latest
practicable date: 7,412,619 shares of common stock as of March 23, 1999.
Documents incorporated by reference: None
2
FORM 10-K INDEX
PART I
ITEM 1. BUSINESS....................................................................................... 1
ITEM 2. PROPERTIES.....................................................................................17
ITEM 3. LEGAL PROCEEDINGS..............................................................................17
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS............................................17
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON STOCK AND RELATED SHAREHOLDER MATTERS...........................18
ITEM 6. SELECTED CONSOLIDATED FINANCIAL DATA...........................................................18
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS..........19
ITEM 7a. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.....................................29
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA....................................................29
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE...........29
PART III
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.............................................30
ITEM 11. EXECUTIVE COMPENSATION.........................................................................32
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.................................36
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.................................................37
PART IV
ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K................................38
3
PART I
ITEM 1. BUSINESS
FORWARD-LOOKING STATEMENTS
Certain statements contained herein constitute "forward-looking statements"
as that term is defined under the Private Securities Litigation Reform Act of
1995. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results, performance
or achievements of the Company, or industry results, to be materially different
from those contemplated or projected, forecasted, estimated or budgeted in or
expressed or implied by such forward-looking statements. Such factors include,
among others, the risk and other factors set forth under "Risk Factors" as well
as the following: general economic and business conditions; industry trends; the
loss of major customers or suppliers; cost and availability of raw materials;
changes in business strategy or development plans; availability and quality of
management; and availability, terms and deployment of capital. SPECIAL ATTENTION
SHOULD BE PAID TO SUCH FORWARD-LOOKING STATEMENTS INCLUDING, BUT NOT LIMITED TO,
STATEMENTS RELATING TO (I) THE COMPANY'S ABILITY TO EXECUTE ITS BUSINESS
STRATEGY (INCLUDING, WITHOUT LIMITATION, WITH RESPECT TO NEW STORE OPENINGS AND
INCREASING THE COMPANY'S PARTICIPATION IN MANAGED VISION CARE PROGRAMS), (II)
THE COMPANY'S ABILITY TO OBTAIN SUFFICIENT RESOURCES TO FINANCE ITS WORKING
CAPITAL AND CAPITAL EXPENDITURE NEEDS AND PROVIDE FOR ITS OBLIGATIONS, (III) THE
CONTINUING SHIFT IN THE OPTICAL RETAIL INDUSTRY OF MARKET SHARE FROM INDEPENDENT
PRACTITIONERS AND SMALL REGIONAL CHAINS TO LARGER OPTICAL RETAIL CHAINS, (IV)
INDUSTRY SALES GROWTH AND CONSOLIDATION AND (V) THE ABILITY OF THE COMPANY TO
MAKE AND INTEGRATE ACQUISITIONS.
GENERAL
Eye Care Centers of America, Inc. ("the Company") is the fourth largest
retail optical chain in the United States as measured by net revenues, operating
or managing 270 stores, 243 of which are optical superstores. The Company
operates predominately under the trade name "EyeMasters," and in certain
geographical regions under the trade names "Visionworks," "Hour Eyes," "Dr.
Bizer's VisionWorld," "Dr. Bizer's ValuVision," "Doctor's ValuVision" and
"Binyon's." The Company utilizes a strategy of clustering its stores within its
targeted markets in order to build local market leadership and strong consumer
brand awareness, as well as to achieve economies of scale in advertising,
management and field overhead. Management believes that the Company has the
number one or two superstore market share position in fourteen of its top
fifteen markets, including Washington, D.C., Houston, Dallas, Tampa/St.
Petersburg, Phoenix, Miami/Ft. Lauderdale, Portland and San Antonio. Based on a
1997 survey conducted on behalf of the Company in seven of its top markets, the
Company has average total brand awareness of 90% and a reputation for quality
service and value. The Company has achieved positive same store sales growth in
each of the past six years and generated net revenues and EBITDA for the fiscal
year ended January 2, 1999, of $237.9 million and $37.2 million, respectively.
4
The Company's stores, which average approximately 4,500 square feet, carry
a broad selection of branded frames at competitive prices, including designer
eyewear such as Armani, Laura Ashley, Calvin Klein and Polo/Ralph Lauren, as
well as its own proprietary brands. In addition, the Company's superstores offer
customers "one-hour service" on most prescriptions, utilizing on-site processing
laboratories to grind, coat and edge lenses. Moreover, independent optometrists
("ODs") located inside or adjacent to all of the Company's stores offer
customers convenient eye exams and provide a consistent source of retail
business. In the Company's experience, over 80% of such ODs' regular eye exam
patients purchase eyewear from the Company.
Since joining the Company as President and Chief Executive Officer in early
1996, Bernard W. Andrews has built a management team with extensive operating,
merchandising and marketing experience in the optical and retail industries.
This management team has focused on improving operating efficiencies and growing
the business through both strategic acquisitions and new store openings. Under
current management, the Company's net revenues has increased from $140.2 million
in fiscal 1995 to $237.9 million in fiscal 1998, while the Company's store base
increased from 152 to 270 over the same period, primarily as a result of three
acquisitions. The Company's senior management team owns or has the right to
acquire approximately 15% of the Company's common stock on a fully diluted
basis, through direct ownership and incentive option plans.
BUSINESS STRATEGY
The Company plans to capitalize on the favorable industry trends discussed
in "Industry" by building local market leadership through the implementation of
the following key elements of its business strategy.
MAXIMIZE STORE PROFITABILITY. Management plans to continue to improve
the Company's operating margins through superior day-to-day store
execution, customer service and inventory asset management. The Company has
implemented various programs focused on (i) increased sales of higher
margin, value-added and proprietary products, (ii) continued store expense
reductions, (iii) extensive productivity-enhancing employee training and
(iv) an upgraded point-of-sale information system. Management believes its
store clustering strategy will enable the Company to continue to leverage
local advertising and field management costs to improve its operating
margins. In addition, management believes that the Company can achieve
further improvement in its operating margins by realizing certain synergies
from its recent acquisitions, particularly from the pending introduction of
its upgraded point-of-sale information system to the acquired stores.
EXPAND STORE BASE. In order to continue to build leadership in its
targeted markets, the Company plans to take advantage of significant
"fill-in" opportunities in its existing markets, as well as enter
attractive new markets where it can achieve a number one or two market
share position. Consequently, the Company currently plans to open twenty to
thirty new stores per year over the next three years, with approximately
two-thirds of these new stores currently expected to be opened in existing
markets. Management believes that the Company has in place the systems and
infrastructure to execute its expanded new store opening plan. The
2
5
Company uses a sophisticated site selection model utilizing proprietary
software which incorporates industry and internally generated data (such as
competitive market factors, demographics and customer specific information)
to evaluate the attractiveness of new store openings. The Company has
reduced the new store site development costs of opening a new store from
approximately $450,000 in 1993 to $400,000 in 1998, by utilizing a smaller
store format averaging approximately 3,500 square feet and by equipping
each new store with standardized fixtures and equipment. In addition,
pre-opening costs average $18,000 and initial inventory requirements for
new stores average $85,000, of which approximately 40% is typically
financed by vendors.
PURSUE ACQUISITION OPPORTUNITIES. The Company has successfully
consummated and integrated three acquisitions over the last three years:
(i) in September 1996, the Company acquired Visionworks Holdings, Inc., and
its subsidiaries (collectively, "Visionworks"), a sixty store optical
retailer located along the Atlantic Coast from Florida to Washington, D.C.,
(the "Visionworks Acquisition"), (ii) in September 1997, the Company
acquired The Samit Group, Inc. and its subsidiaries (collectively, "TSGI"),
with ten Hour Eyes stores in Maryland and Washington, D.C., and certain of
the assets of Hour Eyes Doctors of Optometry, P.C., a Virginia professional
corporation formerly known as Dr. Samit's Hour Eyes Optometrist, P.C. (the
"PC"), and simultaneously entered into a long-term management agreement
with the PC to manage the PC's twelve stores in Virginia (collectively, the
"Hour Eyes Acquisition") and (iii) in September 1998, the Company acquired
certain of the assets of Dr. Bizer's VisionWorld, PLLC and related entities
(the "Bizer Entities"), a nineteen store optical retailer located primarily
in Kentucky and Tennessee, and simultaneously entered into a long-term
management agreement with a private optometrist to manage such nineteen
stores (collectively, the "VisionWorld Acquisition"). Management believes
that it has the experience, internal resources and information systems to
continue to identify and integrate acquisitions successfully. Acquisition
candidates typically would be independent practitioners and smaller chains,
which face increasing difficulties competing with larger, more efficient
chains, particularly in a managed care environment. In addition,
acquisition candidates generally would have significant market share in a
given geographic region and offer the Company opportunities to increase
revenues, generate cost savings and extend managed care coverage.
CAPITALIZE ON MANAGED VISION CARE. Management has made a strategic
decision to pursue managed care contracts aggressively in order to help
grow the Company's retail business and over the past four years has devoted
significant management resources to the development of its managed care
business. As part of its effort, the Company has: (i) implemented direct
marketing programs and information systems necessary to compete for managed
care contracts with large employers, groups of employers and other third
party payors, (ii) developed significant relationships with certain HMOs
and insurance companies (e.g., Kaiser Permanente and Humana), which have
strengthened the Company's ability to secure managed care contracts and
(iii) obtained a single service HMO license in Texas to target additional
managed care contracts with large employers and groups of employers. While
the average ticket price on products purchased under managed care
reimbursement plans is typically lower, managed care transactions generally
earn comparable operating profit margins as they require less promotional
spending and advertising support. The Company believes that the increased
volume resulting from managed care contracts more than offsets
3
6
the lower average ticket price. As of January 2, 1999, the Company
participated in managed vision care programs covering approximately 2.8
million lives, with retail sales from managed care lives totaling
approximately 24% of fiscal 1998 optical sales. Management believes that
the increasing role of managed vision care will continue to benefit the
Company and other large retail optical chains with strong local market
shares, broad geographic coverage and sophisticated information management
and billing systems.
ACQUISITION HISTORY
The Company was incorporated in Texas in 1984, acquired by Sears, Roebuck
and Co. in 1987, acquired by Desai Capital Management Incorporated in 1993 and
the Thomas H. Lee Company recapitalized the Company in April 1998. From its
organization through 1988, the Company expanded its business through the
acquisition of: (i) a thirteen store Phoenix-based chain named 20/20 Eye Care in
1986, (ii) a twelve store Texas and Louisiana-based chain named EyeMasters in
1986, (iii) five stores in Phoenix from EyeCo. in 1988 and (iv) a twenty store
Portland-based chain named Binyon's in 1988.
Since the current management team implemented a strategy focused on
improving operating efficiencies and increasing the store base in early 1996,
the Company has successfully acquired and integrated three acquisitions. In
September 1996, the Company acquired Visionworks Holdings Inc., a sixty store
optical retailer located along the Atlantic Coast from Florida to Washington, D.
C., with forty-nine superstores and eleven optical stores located near Eckerd
Corporation stores. In September 1997, the Company acquired TSGI, with ten Hours
Eyes stores in Maryland and Washington, D.C., and certain of the assets of the
PC, with twelve Hour Eyes stores in Virginia, and simultaneously entered into a
long-term management agreement with the PC to manage the PC's twelve stores in
Virginia. In September 1998, the Company acquired certain of the assets of the
Bizer entities, a nineteen store optical retailer located primarily in Kentucky
and Tennessee operated under the tradenames Dr. Bizer's VisionWorld, Dr. Bizer's
ValuVision and Doctor's ValuVision, and simultaneously entered into a long-term
management agreement with a private optometrist to manage such nineteen stores.
4
7
The following table sets forth a summary of the Company's stores, as of
March 23, 1999, ranked by number of stores by trade name:
NUMBER OF GEOGRAPHIC AVERAGE STORE
TRADE NAME STORES FOCUS FORMAT BUSINESS MIX
---------- ------ ----- ------ ------------
EyeMasters....................................... 155 Southwest, Superstores Glasses
Midwest, Sq. Ft. 4,200 Managed Care
Southeast Lab
OD Subleases
Visionworks...................................... 57 Mid Atlantic, Superstores Glasses
Southeast Sq. Ft. 6,700 Contacts
Lab Managed Care
OD Subleases
Hour Eyes........................................ 25 Mid Atlantic Conventional Glasses
Sq. Ft. 2,200 Contacts
Lab Managed Care
Dr. Bizer's VisionWorld, Dr. Bizer's
ValuVision and Doctor's ValuVision............... 19 Southeast Superstores Glasses
Sq. Ft. 5,800 Contacts
Lab Managed Care
Binyon's......................................... 14 Pacific Superstores Glasses
---
Northwest Sq. Ft. 4,200 Managed Care
Lab
OD Subleases
Total.................................. 270
===
STORE OPERATIONS
OVERVIEW. The Company believes that the location of its stores is an
essential element of its strategy to compete effectively in the optical retail
market. The Company emphasizes locations within regional shopping malls, power
centers, strip shopping centers and free-standing locations. The Company
generally targets retail space that is close to high volume retail anchor stores
frequented by middle to high-income clientele. In order to generate economies of
scale in advertising, management and field overhead expenses, the Company
attempts to cluster its stores within a direct marketing area.
The following table sets forth as of January 2, 1999 the Company's top
fifteen markets and management's estimate of the Company's superstore market
share ranking each of these markets as measured by sales.
NUMBER OF MARKET
DESIGNATED MARKET AREA SUPERSTORES SHARE RANK
--------------------------------- ------------ -----------
Washington, D.C............................................ 25 1
Dallas..................................................... 18 1
Houston.................................................... 17 1
Tampa/St. Petersburg....................................... 12 1
Phoenix.................................................... 12 1
Portland................................................... 12 1
Miami/Ft. Lauderdale....................................... 10 2
Cleveland/Akron............................................ 9 2
Kansas City................................................ 8 2
San Antonio................................................ 8 1
Charlotte.................................................. 5 2
Oklahoma City.............................................. 5 1
Austin..................................................... 5 2
Waco....................................................... 4 1
Orlando.................................................... 4 3
---
Total of Top Fifteen Markets..................... 154
===
5
8
LOCATIONS. The Company operates 270 stores, 243 of which are superstores,
located primarily in the Southwest, Midwest, Southeast, along the Gulf Coast and
Atlantic Coast and in the Pacific Northwest regions of the United States. Of the
Company's stores, 139 are located in enclosed regional malls, 77 are in strip
shopping centers, 49 are freestanding locations and five are located near Eckerd
Corporation stores.
The following table sets forth by location, ranked by number of stores, the
Company's store base as of March 23, 1999.
LOCATION EYEMASTERS VISIONWORKS HOUR EYES VISIONWORLD BINYON'S TOTAL
---------------- ---------- ----------- --------- ----------- -------- -----
Texas.......................... 70 -- -- -- -- 70
Florida........................ 3 38 -- -- -- 41
Tennessee...................... 7 -- -- 10 -- 17
Virginia....................... -- 3 13 -- -- 16
North Carolina................. -- 13 -- -- -- 13
Oregon......................... -- -- -- -- 13 13
Arizona........................ 12 -- -- -- -- 12
Louisiana...................... 12 -- -- -- -- 12
Ohio........................... 9 -- -- -- -- 9
Maryland....................... -- -- 9 -- -- 9
Kentucky....................... -- -- -- 7 -- 7
Missouri....................... 6 -- -- 1 -- 7
Oklahoma....................... 7 -- -- -- -- 7
Kansas......................... 5 -- -- -- -- 5
Alabama........................ 4 -- -- -- -- 4
New Mexico..................... 3 -- -- -- -- 3
Nevada......................... 3 -- -- -- -- 3
Mississippi.................... 3 -- -- -- -- 3
Idaho.......................... 3 -- -- -- -- 3
Nebraska....................... 3 -- -- -- -- 3
South Carolina................. -- 3 -- -- -- 3
Washington, D.C................ -- -- 3 -- -- 3
Utah........................... 2 -- -- -- -- 2
Washington..................... 1 -- -- -- 1 2
Georgia........................ 1 -- -- -- -- 1
Indiana........................ -- -- -- 1 -- 1
Iowa........................... 1 -- -- -- -- 1
--- -- -- -- -- ---
Total................ 155 57 25 19 14 270
=== == == == == ===
STORE LAYOUT AND DESIGN. The average size of the Company's stores is
approximately 4,500 square feet. In the last two years, the Company has
developed and implemented a smaller and more efficient new store prototype,
which averages approximately 3,500 square feet in size. This new store prototype
typically has approximately 450 square feet dedicated to the in-house lens
processing area and 1,750 square feet devoted to product display and fitting
areas. The optometrist's office is generally 1,300 square feet and is, depending
on state regulation, either in or adjacent to the store. Each store follows a
uniform merchandise layout plan, which is designed to emphasize fashion, invite
customer browsing and enhance the customer's shopping experience. Frames are
displayed in self-serve cases along the walls and on tabletops located
throughout the store and are organized by gender suitability and frame style.
The Company believes its self-serve displays are more effective than the less
customer friendly locked glass cases or "under the shelf" trays used by some of
its competitors. Above the display racks are photographs of men and women which
are designed to help customers coordinate frame shape and color with their
facial features. In-store displays and signs are rotated periodically to
emphasize key vendors and new styles.
6
9
IN-HOUSE LENS PROCESSING. Most stores have an on-site lens-processing
laboratory of approximately 450 square feet in which most prescriptions can be
prepared in one hour or less. Lens processing involves grinding, coating and
edging lenses. Unusual or difficult prescriptions are sent to the Company's main
laboratory in San Antonio, Texas, which has a typical turnaround of two to four
days.
ON-SITE OPTOMETRIST. All stores have an OD, located in or adjacent to the
store, who performs eye examinations, and in some cases dispenses contact
lenses. The ODs are generally available during the same hours as the Company's
store hours. The ODs offer customers convenient eye exams and provide a
consistent source of retail business. In the Company's experience, over 80% of
such ODs' regular eye exam patients purchase eyewear from the Company. In
addition, the Company believes proficient ODs help to generate repeat customers
and reinforce the quality and professionalism of each store. Due to state
regulations, ODs are generally independent business persons who lease space
inside or adjacent to each store from the Company or the landlord. Most ODs pay
the Company monthly rent consisting of a percentage of gross receipts, base
rental or a combination of both.
STORE MANAGEMENT. Each store has an operating plan, which maps out
appropriate staffing levels to maximize store profitability. In addition, each
store is run by a general manager who is responsible for its day-to-day
operations. In higher volume locations, a retail manager supervises the
merchandising area and the eyewear specialists. A lab manager trains the lab
technicians and supervises eyewear manufacturing. Sales personnel are trained to
assist customers effectively in making purchase decisions. A portion of store
managers' and territory directors' compensation is based on sales, profitability
and customer service scores at their particular stores. The stores are open
during normal retail hours, typically 10 a.m. to 9 p.m., six days a week, and
typically 12:00 p.m. to 6:00 p.m. on Sundays.
MERCHANDISING
The Company's merchandising strategy is to offer its customers a wide
selection of high quality and fashionable frames at various price points, with
particular emphasis on offering a broad selection of competitively priced
designer and branded frames. The Company's product offering is supported by
strong customer service and advertising. The key elements of the Company's
merchandising strategy are described below.
BREADTH AND DEPTH OF SELECTION. The Company offers its customers high
quality frames, lenses, accessories and sunglasses, including designer and
private label frames. Frame assortments are tailored to match the demographic
composition of each store's market area. On average, each store contains between
1,500 and 2,000 frame stock keeping units in 350 to 400 different styles of
frames. This represents two to three times the assortment provided by
conventional chains or independent retailers. Approximately 25% of the frames
carry designer names such as Polo, Armani, Gucci, Liz Claiborne, Laura Ashley
and Calvin Klein. In fiscal 1998, over 50% of the Company's frames were supplied
by other well-known frame manufacturers and about 14% of the Company's frames
were manufactured specifically for the Company under private labels. The Company
believes that a broader selection of high-quality, lower-priced private label
frames allow it to offer more value to customers while improving the
7
10
Company's gross margin. In addition, the Company also offers customers a wide
variety of value-added eyewear features and services on which it realizes a
higher gross margin. These include thinner and lighter lenses, progressive
lenses and customer lens features, such as tinting, anti-reflecting coatings,
scratch-resistant coatings, ultra-violet protection and edge polishing.
PROMOTIONAL STRATEGY. The Company's frames and lenses are generally
comparably priced or priced lower than its direct superstore competitors, with
prices varying based on geographic region. The Company employs a comprehensive
promotional strategy on a wide selection of frames and/or lenses, offering
discounts and "two for one" promotions. These promotions are highly effective at
attracting customers to shop the Company's stores. While the promotional
strategy is fairly common for optical retail chains, independents tend to offer
fewer promotions in order to guard their margins and mass merchandisers tend to
generally adhere to an "Every Day Low Pricing" strategy.
EFFECTIVE PRODUCT DISPLAY. The Company employs an "easy-to-shop" store
layout. Merchandise in each store is organized by gender suitability, frame
style and brand. Sales personnel are trained to assist customers in selecting
frames, which complement an individual's attributes such as facial features,
face shape and skin tone. See "- Store Layout and Design." In-store displays
focus customer attention on premium priced products, such as designer frames and
thinner and lighter lenses.
MARKETING
The Company actively supports its stores by aggressive local advertising in
individual geographical markets. Advertising expenditures totaled $23.8 million,
or 10.0% of net revenues, in fiscal 1998. The Company utilizes a variety of
advertising media and promotions in order to establish the Company's image as a
high quality, cost competitive eyewear provider with a broad product offering.
The Company's brand positioning is supported by a marketing campaign which
features the tagline "See Better, Look Better." Through this campaign, the
Company has recognized an increase in top of mind brand awareness with
consumers. In addition, the Company's strategy of clustering stores in each
targeted market area allows it to maximize the benefit of its advertising
expenditures. As managed care becomes a larger part of the Company's business in
certain local markets, advertising expenditures as a percentage of sales are
likely to decrease in those markets, since managed care programs tend to reduce
the need for marketing expenditures to attract customers to shop the Company's
stores.
STORE EXPANSION
The Company's business strategy is to continue to grow through the opening
of additional locations through selected store acquisitions. The Company has an
aggressive but disciplined new store expansion strategy. The Company currently
plans to open between twenty to thirty new stores per year over the next three
years, with approximately two-thirds of these new stores currently expected to
be opened in existing markets. The new stores are expected to have an on-site OD
and a lens-processing laboratory. To determine which new markets to enter, the
Company uses a sophisticated site selection model utilizing proprietary software
which incorporates industry and internally generated data (such as competitive
market factors,
8
11
demographics and customer specific information) to evaluate the attractiveness
of new store openings. The Company has reduced the new store site development
costs of opening a new store from approximately $450,000 in fiscal 1993 to
$400,00 in fiscal 1998, by utilizing a smaller store format averaging
approximately 3,500 square feet and by equipping each new store with
standardized fixtures and equipment. In addition, pre-opening costs average
$18,000 and initial inventory requirements for new stores average $85,000, of
which approximately 40% is typically financed by vendors.
EMPLOYEE TRAINING
The Company believes that its dedication to employee training has improved
customer service, increased morale among its employees and contributed to the
Company's increased productivity levels. Each new employee with no prior
experience in the optical industry receives approximately eighty hours of
initial training. New employees with previous optical experience receive
approximately forty hours of initial training. Store managers participate in
approximately fifty hours of annual training. The American Board of Opticianry
("ABO") has certified the Company to offer up to seventy hours of ABO continuing
education credits to maintain opticianary-licensing requirements. Employee
training emphasizes customer service, thorough product and service knowledge,
optical knowledge, lab skills, selling techniques and the utilization of store
performance data to better manage day-to-day store operations. Store level
employees may also be cross-trained in sales and lab-related skills to promote
increased staffing flexibility. Ongoing training is conducted periodically to
familiarize management and employees with new products and services, to improve
the level of understanding of store operations and productivity and to maintain
the Company's overall high quality standards.
COMPETITION
The retail optical industry is fragmented and highly competitive. The
Company competes with (i) independent practitioners (including opticians,
optometrists and ophthalmologists) (ii) optical retail chains (including
superstores) and (iii) mass merchandisers and warehouse clubs. From time and
time, competitors have launched aggressive promotional programs, which have
temporarily impacted the Company's ability to achieve comparable stores sales
growth and maintain gross margin. Some of the Company's competitors are larger,
have longer operating histories, greater financial resources and greater market
recognition than the Company.
VENDORS
The Company purchases a majority of its lenses from three principal vendors
and purchases frames from over twenty different vendors. In fiscal 1998, three
vendors collectively supplied approximately 37% of the frames purchased by the
Company. Two vendors supplied over 61% of the Company's lens materials during
the same period. While such vendors supplied a significant share of the lenses
used by the Company, lenses are a generic product and can be purchased from a
number of other vendors on comparable terms. The Company therefore does not
believe that it is dependent on such vendors or any other single vendor for
frames or lenses. The Company believes that its relationships with its existing
vendors are satisfactory. The Company believes that significant disruption in
the delivery of merchandise from one or more of
9
12
its current principal vendors would not have a material adverse effect on the
Company's operations because multiple vendors exist for all of the Company's
products.
MANAGED VISION CARE
In recent years, managed vision care has grown in importance in the eyewear
market as health insurers have sought to gain a competitive advantage by
offering a full range of health insurance options, including coverage of primary
eye care. Managed vision care, including the benefits of routine annual eye
examinations and eyewear discounts, is being utilized by a growing number of
managed care participants. Since regular eye examinations may assist in the
identification and prevention of more serious conditions, managed care programs
encourage members to have their eyes examined more regularly, which in turn
typically results in more frequent eyewear replacement.
While the average ticket price on products purchased under managed care
reimbursement plans is typically lower, managed care transactions generally earn
comparable operating profit margins as they require less promotional spending
and advertising support. The company believes that the increased volume
resulting from managed care contracts more than offsets the lower average ticket
price.
While managed vision care encompasses many of the conventional attributes of
managed care, there are significant differences. For example, there is no
medical risk involved, as these programs cover only a customer's eye examination
and no medical condition of such customer. Moreover, less than 1% of the
Company's total revenues are derived from traditional capitated managed care
programs. In capitated programs, the Company is compensated by a third party on
a per member per month flat fee basis. The Company allocates such payment
between the provider of services: the OD for eye examinations performed and the
Company for eyewear purchased. The Company receives less than $500,000 of eye
examination related revenue. The Company does not employ the ODs who perform
such eye examinations, and therefore believes it is not engaged in the corporate
practice of medicine. Since the number of visits to an OD is limited to annual
or bi-annual appointments, exam utilization is more predictable, so costs to
insurers are easier to quantify, generally resulting in lower capitation risk.
Even though managed vision care programs typically limit coverage to a certain
dollar amount or discount for an eyewear purchase, the member's eyewear benefit
generally allows the member to "trade up." Management believes that the growing
consumer perception of eyewear as a fashion accessory as well as the consumer's
historical practice of paying for eyewear purchases out-of-pocket contributes to
the frequency of "trading-up." The Company has historically found that managed
care participants who take advantage of the eye exam benefit under the managed
care program in turn have typically had their prescriptions filled at adjacent
optical stores.
Management has made a strategic decision to pursue managed care contracts
aggressively in order to help grow the Company's retail business and over the
past four years has devoted significant management resources to the development
of this business. As part of its effort, the Company has: (i) implemented direct
marketing programs and information systems necessary to compete for managed care
contracts with large employers, groups of employers and other third party
payers, (ii) developed significant relationships with certain HMOs and insurance
10
13
companies (e.g., Kaiser Permanente and Humana), which have strengthened the
Company's ability to secure managed care contracts, and (iii) obtained a single
service HMO license in Texas to target additional managed care contracts with
large employers and groups of employers.
As of January 2, 1999, the Company participated in managed vision care
programs covering approximately 2.8 million lives, with retail sales from
managed care lives totaling approximately 24% of fiscal 1998 optical sales.
Management believes that the increasing role of managed vision care will
continue to benefit the Company and other large retail optical chains. Managed
care is likely to accelerate industry consolidation as payers look to contract
with large retail optical chains who deliver superior customer service, have
strong local brand awareness, offer competitive prices, provide multiple
convenient locations and hours of operation, and possess sophisticated
information management and billing systems. Large optical retail chains are
likely to be the greatest beneficiaries of this trend as independents cannot
satisfy the scale requirements of managed care programs and mass merchandisers'
"Every Day Low Price" strategy is generally incompatible with the price
structure required by the managed vision care model.
GOVERNMENT REGULATION
The Company or its landlord leases a portion of each of the Company's stores
or adjacent space to an independent optometrist. The availability of such
professional services in or adjacent to the Company's stores is critical to the
Company's marketing strategy. The delivery of health care, including the
relationships among health care providers such as optometrists and suppliers
(e.g., providers of eyewear), is subject to extensive federal and state
regulation. The laws of many states prohibit business corporations such as the
Company from practicing medicine or exercising control over the medical
judgments or decisions of physicians and from engaging in certain financial
arrangements, such as splitting fees with physicians. In certain situations, to
address and comply with certain regulatory restrictions the Company and
independent optometrist have entered into long-term management contracts whereby
the Company (through its subsidiaries) manage the optical dispensary and certain
limited aspects of professional practice of the independent optometrist instead
of owning the store and employing the optometrists directly.
Other than local and state business licenses, the Company is not currently
required to maintain any licenses or certificates to operate its business in any
state. However, as a result of the capitation element of some of its managed
care contracts, the Company is required in the states of North Carolina, Texas
and California to obtain insurance licenses and to comply with certain routine
insurance laws and regulations as an insurer in order to offer managed care
discount programs to various employee groups within such states. The cost of
such compliance is minimal. These insurance laws require that the Company make
certain mandatory filings with the state relating to: (i) pertinent financial
information and (ii) quality of care standards. Violation of any of these laws
or regulations could possibly result in the Company incurring monetary fines
and/or other penalties. The Company is currently in material compliance with
each of these laws and regulations.
The fraud and abuse provisions of the Social Security Act and anti-kickback
laws and regulations adopted in many states prohibit the solicitation, payment,
receipt, or offering of any
11
14
direct or indirect remuneration in return for, or as an inducement to, certain
referrals of patients, items or services. Provisions of the Social Security Act
also impose significant penalties for false or improper billings to Medicare and
Medicaid, and many states have adopted similar laws applicable to any payor of
health care services. In addition, the Stark Self-Referral Law imposes
restrictions on physicians' referrals for designated health services
reimbursable by Medicare or Medicaid to entities with which the physicians have
financial relationships, including the rental of space if certain requirements
have not been satisfied. Many states have adopted similar self-referral laws
which are not limited to Medicare or Medicaid reimbursed services. Violations of
any of these laws may result in substantial civil or criminal penalties,
including double and treble civil monetary penalties, and, in the case of
violations of federal laws, exclusion from participation in the Medicare and
Medicaid programs. Such exclusions and penalties, if applied to the Company,
could have a material adverse effect on the Company. The Company is currently in
material compliance with all of the foregoing laws and no determination of any
violation in any state has been made with respect to the foregoing laws.
TRADEMARK AND TRADE NAMES
The Company's superstores operate under the trade names "EyeMasters,"
"Binyon's," "Visionworks," "Hour Eyes," "Dr. Bizer's VisionWorld," "Dr. Bizer's
ValuVision" and "Doctor's ValuVision." In addition, "SlimLite" is the Company's
trademark for its line of lightweight plastic lenses and "SunMasters" is the
trade name for the sunglass kiosk within the "EyeMasters" superstore. Other
trademarks and trade names used by the Company are "Master Eye Associates,"
"Master Eye Exam," "EyeMasters" and the "eyeball" mark used in conjunction with
the trade name "EyeMasters."
EMPLOYEES
As of January 2, 1999, the Company employed approximately 3,500 employees.
The Company's employees are not covered by any collective bargaining agreements,
and the Company considers its relations with its employees to be good.
THE RECAPITALIZATION
On March 6, 1998, ECCA Merger Corp. ("Merger Corp."), a Delaware corporation
formed by Thomas H. Lee Company ("THL Co."), and the Company entered into a
recapitalization agreement (the "Recapitalization Agreement") providing for,
among other things, the merger of such corporation with and into the Company
(the "Merger" and, together with the financing of the recapitalization and
related transactions described below, the "Recapitalization"). Upon consummation
of the Recapitalization on April 24, 1998, Thomas H. Lee Equity Fund IV, L.P.
("THL Fund IV") and other affiliates of THL Co. (collectively with THL Fund IV
and THL Co., "THL") owned approximately 89.7% of the issued and outstanding
shares of common stock of the Company ("Common Stock"), existing shareholders
(including management) of the Company retained approximately 7.3% of the issued
and outstanding Common Stock and management purchased additional shares
representing approximately 3.0% of the issued and outstanding Common Stock. The
total transaction value of the Recapitalization was
12
15
approximately $323.8 million, including related fees and expenses, and the
implied total equity value of the Company following the Recapitalization is
approximately $107.3 million.
Certain of the funds needed to consummate the Recapitalization were
obtained through the sale, pursuant to Rule 144A promulgated under the
Securities Act of 1933, as amended (the "Securities Act"), of $100,000,000 in
principal amount of 9 1/8% Senior Subordinated Notes due 2008(the "Fixed Rate
Notes") and $50,000,000 in principal amount of Floating Interest Rate
Subordinated Term Securities due 2008 (the "Floating Rate Notes" and together,
with the Fixed Rate Notes, the "Initial Notes"). The Initial Notes were issued
by the Company and guaranteed by the subsidiary guarantors. Under that certain
Indenture, dated April 24, 1998 (the "Indenture"), by and among the Company, the
subsidiary guarantors, and the United States Trust Company of New York as
Trustee governing the Initial Notes, the Company and the subsidiary guarantors
are jointly and severally liable for payment of the Initial Notes. In addition
to the net proceeds from the sale of the Initial Notes, the Recapitalization was
financed with (a) approximately $55.0 million of borrowings under the New Credit
Facility (see "Introduction" in Management's Discussion and Analysis of
Financial Condition and Results of Operation) and (b) approximately $99.4
million from the sale of capital stock to THL, Bernard W. Andrews and other
members of management (the "Equity Contribution") consisting of (i)
approximately $71.6 million from the sale of Common Stock and (ii) approximately
$27.8 million from the sale of shares of a newly created series of preferred
stock of the Company ("New Preferred Stock"). See "Description of New Preferred
Stock." The Company used the proceeds from such bank borrowings, the sale of the
Initial Notes, and the Equity Contribution principally to finance the conversion
into cash of the shares of Common Stock which were not retained by existing
stockholders, to refinance certain existing indebtedness of the Company, to
redeem certain outstanding preferred stock of the Company and to pay related
fees and expenses of the Recapitalization. In connection with the
Recapitalization, the Company in-substance defeased its previously issued 12%
Senior Notes due 2003 (the "Senior Notes") by depositing with the trustee for
the Senior Notes (i) an irrevocable notice of redemption of the Senior Notes on
October 1, 1998 and (ii) United States government securities in an amount
necessary to yield on October 1, 1998 $78.4 million, which constituted the
principal amount, premium and interest payable on the Senior Notes on the
October 1, 1998 redemption date. The Senior Notes were defeased as scheduled on
October 1, 1998.
The Company filed a registration statement with the Securities and Exchange
Commission with respect to an offer to exchange the Initial Notes for notes
which have terms substantially identical in all material respects to the Initial
Notes, except such notes are freely transferable by the holders thereof and are
issued without any covenant regarding registration (the "Exchange Notes"). The
registration statement was declared effective on January 28, 1999. The exchange
period ended March 4, 1999. The Exchange Notes are the only notes of the Company
which are currently outstanding.
SEASONALITY AND QUARTERLY RESULTS
The company's sales fluctuate seasonally. Historically, the Company's
highest sales and earnings occur in the first and third quarters. In addition,
quarterly results are affected by the opening of new stores; therefore, the
Company's growth, the Visionworks Acquisition, the Hour Eyes Acquisition and the
VisionWorld Acquisition may affect seasonal fluctuations. Hence, quarterly
results are not necessarily indicative of results for the entire year.
INDUSTRY
OVERVIEW. Optical retail sales in the United States totaled $15.4 billion in
1997, according to industry sources. Since 1987, the optical retail market has
grown each year at an average annual rate of approximately 5%. Management
believes that the industry will continue to grow at a similar rate over the next
several years due to a number of favorable trends discussed below.
13
16
The following chart sets forth expenditures (based upon products sold) in the
optical retail market over the past seven years according to a leading industry
publication.
U.S. OPTICAL RETAIL SALES BY SECTOR 1991 -- 1997
(DOLLARS IN BILLIONS)
1997
1991 1992 1993 1994 1995 1996 1997 SHARE
------- ------- ------- ------- ------- ------- -------- -----
Lenses/treatments $ 5.2 $ 5.6 $ 6.0 $ 6.5 $ 6.8 $ 7.2 $ 7.6 49.5%
Frames 3.9 4.0 4.1 4.1 4.4 4.6 5.0 32.2
Sunglasses(a) 0.5 0.5 0.5 0.5 0.7 0.8 0.9 5.8
Contact lenses 1.8 1.8 1.7 1.8 1.9 1.9 1.9 12.5
------- ------- ------- ------- ------- ------- -------- -----
$ 11.5 $ 11.9 $ 12.3 $ 12.9 $ 13.8 $ 14.6 $ 15.4 100.0%
======= ======= ======= ======= ======= ======= ======== =====
- ----------
(a) Does not include sales through specialty optical retailers or general retail
channels.
Distribution. Eye care services in the United States are delivered by local
providers consisting of approximately 65,000 opticians, 31,000 optometrists and
16,500 ophthalmologists. The optical retail industry in the United States is
highly fragmented and consists of (i) independent practitioners (including
opticians, optometrists and ophthalmologists), (ii) optical retail chains and
(iii) warehouse clubs and mass merchandisers. In 1997, optical retail chains
accounted for approximately 32.5% of the total market, while independent
practitioners comprised approximately 61.5% and other distribution channels
represented approximately 6.0%. Optical retail chains have begun consolidating
the optical retail market at the expense of independent practitioners.
Independent practitioners' market share dropped from 63.0% to 61.5% between 1996
and 1997, while optical retail chains' market share increased over the same
period from 31.3% to 32.5%.
Independent Practitioners. In 1997, independent practitioners represented
$9.5 billion of eyewear retail sales, or 61.5% of the industry's total optical
retail sales volume of $15.4 billion. Independent practitioners typically cannot
provide quick turnaround of eyeglasses because they do not have laboratories on
site and generally charge higher prices than other competitors. Moreover, their
eyewear product assortment is usually narrow, although a growing portion
includes some designer or branded products. Prior to 1974, independent
practitioners benefited from regulatory and other factors which inhibited
commercial retailing of prescription eyewear. In 1974, the Federal Trade
Commission began requiring doctors to provide their patients with copies of
their prescriptions, enabling sophisticated retailers to implement retail
marketing concepts which gave way to a more competitive marketplace. Independent
practitioners' market share has declined from approximately 100% in 1974 to
61.5% in 1997, dropping 1.5% from 1996. Management believes that independent
practitioners will continue to lose market share over the next several years.
Optical Retail Chains. Optical retail chains represented 32.5% of the total
optical retail market in 1997. Over the past three years, the top one hundred
optical retail chains (in terms of net revenues) have grown at a rate faster
than the overall market. Optical retail chains include both superstores and
conventional optical stores. Optical retail chains offer quality service
provided by on-site optometrists and also carry a wide product line, emphasizing
the fashion element of eyewear,
14
17
although lower-priced lenses and frames are also available. In addition, the
retail optical chains, particularly the superstores, are generally able to offer
better value and service through a reduced cost structure, sophisticated
merchandising and display, economies of scale and greater volume. Furthermore,
they can generate greater market awareness than can fragmented independent
practitioners as optical retail chains usually invest more in advertising and
promotions. Management believes that large optical chains are best positioned to
benefit from industry consolidation trends including the growth in managed
vision care.
Warehouse Clubs and Mass Merchandisers. Warehouse clubs and mass
merchandisers usually provide eyewear in a host environment which is typically a
larger general merchandise store. This segment typically provides some of the
service elements of retail optical chains, but competes primarily on price. As a
result, its eyewear selection tends to focus on lower-priced optical products.
Moreover, this segment's "Every Day Low Price" strategy is generally
incompatible with the pricing structure required by the managed vision care
model. Warehouse clubs and mass merchandisers' market share declined from 4.2%
in 1996 to 4.0% in 1997.
Other. Other participants in the optical retail market include HMOs and
school-controlled dispensaries. In 1997, other participants represented
approximately 2.0% of the total optical retail market.
TRENDS. Management believes that growth and consolidation in the optical
retail market is being driven by the following trends:
Favorable Demographics. Approximately 60% of the U.S. population, or 160
million individuals, and nearly 95% of people over the age of forty-five,
require some form of corrective eyewear. In addition to their higher utilization
of corrective eyewear, the over forty-five segment spends more per pair of
glasses purchased due to their need for premium priced products like bifocals
and progressive lenses and their generally higher levels of discretionary
income. In 1996, the over forty-five segment represented 58% of retail optical
spending despite representing just 33% of the U.S. population. As the "baby
boom" generation ages and life expectancies increase, management believes that
this demographic trend is likely to increase the number of eyewear customers and
the average price per purchase.
Increasing Role of Managed Vision Care. Management believes that optical
retail sales through managed vision care programs, which were approximately $4.1
billion (or approximately 30% of the market) in 1995, will continue to increase
over the next several years. Managed vision care, including the benefits of
routine annual eye examinations and eyewear discounts, is being utilized by a
growing number of managed care participants. Since regular eye examinations may
assist in the identification and prevention of more serious conditions, managed
care programs encourage members to have their eyes examined more regularly,
which in turn typically results in more frequent eyewear replacement. Management
believes that large optical retail chains are likely to be the greatest
beneficiaries of this trend as payers look to
15
18
contract with chains who deliver superior customer service, have strong local
brand awareness, offer competitive prices, provide multiple convenient locations
and flexible hours of operation, and possess sophisticated information
management and billing systems.
Consolidation. Although the optical retail market in the United States is
highly fragmented, the industry is experiencing increasing consolidation. In
1997, the top ten and the top one hundred optical retail chains represented
approximately 18% and 28% of the total optical market, respectively. The
remaining approximately 72% of the market includes independent practitioners,
smaller chains, warehouse clubs and mass merchandisers. Independent
practitioners' market share dropped from 63.0% to 61.5% between 1996 and 1997,
while optical retail chains' market share increased over the same period from
31.3% to 32.5%. Management believes that several factors are likely to drive
further consolidation: (i) the importance of scale to managed care programs
which require providers with strong store brand awareness, multiple locations
and sophisticated information management and billing systems, (ii) efficiencies
of scale in merchandising, marketing, manufacturing and sourcing product, (iii)
the significant capital required to build lens processing laboratories on
premises and (iv) the desire of small regional chains and independent
practitioners to achieve liquidity by selling to larger optical retail chains.
Management believes that the large optical retail chains are better positioned
than mass merchandisers and warehouse clubs to benefit from this consolidation
trend and that such chains will continue to gain market share from the
independent practitioners over the next several years.
New Product Innovations. Since the late 1980's, several technological
innovations have led to the introduction of new optical lenses and lens
treatments, including progressive addition lenses (no-line bifocals), high-index
and aspheric lenses (thinner and lighter), polycarbonate lenses (shatter
resistant) and anti-reflective coatings. These innovative products are popular
among consumers, generally command premium prices and yield higher margins than
traditional lenses. The average retail price for all lenses and lens treatments
has increased over 4% per year from $87.94 to $95.50 between 1995 and 1997,
reflecting, in part, the rising popularity of these products. Similarly, during
the same period, the average retail price for eyeglass frames has increased over
4% per year from $57.03 to $62.20, due in large part to both technological
innovation and an evolving customer preference for higher priced, branded
frames.
Greater Frequency of Purchase. Since 1983, the frequency of eyewear
purchases has increased over 45%, from an average purchase of new eyewear every
2.2 years to every 1.5 years. Management believes that managed care has
contributed to this trend and is likely to serve as a continuing catalyst to
further increases in the frequency of eyewear purchases, as plan participants
are encouraged to have their eyes examined more frequently. In addition,
consumers are currently purchasing multiple eyewear products for distinct
occasions (work, casual, fashion, driving, sun, sport, etc.), driven, in part,
by the growing consumer perception of eyewear as a fashion accessory.
16
19
ITEM 2. PROPERTIES
As of March 23, 1999, the Company operated 270 retail locations in the
United States. The Company believes its properties are adequate and suitable for
its purposes. The Company leases all its retail locations, the majority of which
are under triple net leases that require payment by the Company of its pro rata
share of real estate taxes, utilities, and common area maintenance charges.
These leases range in terms of up to 15 years. Certain leases require percentage
rent based on gross receipts in excess of a base rent. The Company subleases a
portion of substantially all of the stores or the landlord leases an adjacent
space, to an independent optometrist or a corporation controlled by an
independent optometrist. The terms of these leases or subleases range from one
to fifteen years, with rentals consisting of a percentage of gross receipts, a
base rental, or a combination of both. The general character of the Company's
stores is described in Item 1 of this report.
The Company leases combined corporate offices and a retail location in San
Antonio, Texas, pursuant to a fifteen-year lease. In addition, the Company
leases a combined distribution center and central laboratory in San Antonio,
pursuant to a seven-year lease. The Company believes central distribution
improves efficiency through better inventory management and streamlined
purchasing.
ITEM 3. LEGAL PROCEEDINGS
The Company is a party to routine litigation in the ordinary course of its
business. Except for the matters set forth below, no such pending matters,
individually or in the aggregate, are deemed to be material to the business or
financial condition of the Company.
The Government of the District of Columbia, Office of Corporate Counsel has
terminated its investigation relating to Medicaid claims submitted for
reimbursement by certain optometrists who provided services from (i) one Hour
Eyes store located in Washington, D.C. which was subsequently acquired by the
Company in connection with the Hour Eyes Acquisition and (ii) one other Hour
Eyes store located in Washington, D.C. which was not acquired by the Company but
which was under common control with the corporation which sold certain Hour Eyes
stores to the Company in 1997. This matter has been referred to the Commission
of Health Care Finance for the Department of Health Care for the District of
Columbia (the "Health Commission") for further handling and disposition. The
Company is entitled to certain rights of indemnification with respect to matters
arising out of this investigation under the stock purchase agreement relating to
the Hour Eyes Acquisition, and a limited dollar amount has been set aside in an
escrow account to secure the sellers' indemnification obligations. In light of
the on-going investigation by the Health Commission, the Company at this time is
unable to determine whether any action or claim will be brought against the
Company or, if brought, the precise nature or extent of any such action or
claim. No assurance can be given that the Health Commission or any other
governmental body will not bring an action, assert one or more claims or seek
material damages, interest, fines and/or penalties, including criminal
penalties, against the Company for matters arising out of this investigation.
The Company believes the indemnification arrangement under this agreement is
reasonably adequate to satisfy any assessed penalties.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None to be reported.
17
20
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON STOCK AND RELATED
SHAREHOLDER MATTERS
The Common Stock, par value $.01 per share, of the Company is not traded on
any established public trading market. There are 18 holders of the Common Stock
and no dividends were paid in fiscal 1997 or 1998. See "The Recapitalization."
ITEM 6. SELECTED CONSOLIDATED FINANCIAL DATA
The following table sets forth selected financial data and other operating
information of the Company. The selected financial data in the table are derived
from the consolidated financial statements of the Company. The following
selected financial data should be read in conjunction with the Consolidated
Financial Statements, the related notes thereto and other financial information
included elsewhere in this Annual Report on Form 10-K. All references in this
Annual Report on Form 10-K to a year or a fiscal year shall mean the fiscal year
ended December 31 of such year, except references herein to 1996 or fiscal 1996,
1997 or fiscal 1997 and 1998 or fiscal 1998 relate to the fiscal years ended
December 28, 1996, January 3, 1998 and January 2, 1999 respectively.
Years Ended
-------------- --------------- --------------- --------------- ----------------
December 31, December 30, December 28, January 3, January 2,
1994 1995 1996 1998 1999
-------------- --------------- --------------- --------------- ----------------
STATEMENT OF OPERATIONS DATA:
(DOLLARS IN THOUSANDS)
Net revenues $ 130,673 $ 140,198 $ 158,224 $ 219,611 $ 237,851
Operating costs and expenses:
Cost of goods sold 45,240 47,525 51,884 77,134 80,636
Selling, general and
administrative (a) 81,434 87,402 91,897 120,319 132,390
Recapitalization and other
expenses -- -- -- -- 25,803
Amortization of intangible assets 10,542 5,551 2,938 2,870 3,705
--------- --------- --------- --------- ---------
Total costs and expenses 137,216 140,478 146,719 200,323 242,534
--------- --------- --------- --------- ---------
Operating income (loss) (6,543) (280) 11,505 19,288 (4,683)
Interest expense, net 9,072 8,839 9,899 13,738 19,159
In-substance defeased bonds interest
expense, net -- -- -- -- 2,418
--------- --------- --------- --------- ---------
Income (loss) before income taxes (15,615) (9,119) 1,606 5,550 (26,260)
Income tax expense -- -- 188 335 13
--------- --------- --------- --------- ---------
Net income (loss) before
extraordinary item (15,615) (9,119) 1,418 5,215 (26,273)
Extraordinary loss on early extinguishment
of long-term debt -- -- -- -- 8,355
--------- --------- --------- --------- ---------
Net income (loss) $ (15,615) $ (9,119) $ 1,418 $ 5,215 $ (34,628)
========= ========= ========= ========= =========
OTHER FINANCIAL DATA:
Depreciation and amortization (b) $ 20,675 $ 15,229 $ 12,449 $ 15,001 $ 16,050
Capital expenditures 5,367 6,765 4,233 9,470 20,656
Gross Margin % 65.4% 66.1% 67.2% 64.9% 66.1%
Ratio of earnings to fixed -- -- 1.11x 1.27x 0.1x
charges(c)
MISCELLANEOUS DATA:
EBITDA (d) $ 14,132 $ 14,949 $ 23,954 $ 34,289 $ 37,170
EBITDA margin % 10.8% 10.7% 15.1% 15.6% 15.6%
Comparable store sales growth (e) 1.1% 4.2% 3.5% 3.8% 1.1%
End of period stores 162 152 218 239 270
Sales per store (f) $ 878 $ 904 $ 935 $ 995 $ 1,007
18
21
- ----------
(a) The Company recorded a $0.7 million non-cash impairment charge related to
its investment in its subsidiary in Mexico, which is included in selling,
general and administrative expenses for 1996.
(b) Depreciation and amortization shown here does not include the amortization
of store pre-opening costs, which is included in selling, general and
administrative expenses.
(c) In computing the ratio of earnings to fixed charges, "earnings" represents
income (loss) before income tax expense plus fixed charges. "Fixed charges"
consists of interest, amortization of debt issuance costs and a portion of
rent, which is representative of interest factor (approximately one-third
of rent expense). For the years ended December 31, 1994 and December 30,
1995, earnings were insufficient to cover fixed charges by $15.6 million
and $9.1 million, respectively.
(d) EBITDA represents consolidated net income (loss) before interest expense,
income taxes, depreciation and amortization (other than amortization of
store pre-opening costs) and recapitalization and other expenses. The
Company has included information concerning EBITDA because it believes that
EBITDA is used by certain investors as one measure of a company's
historical ability to fund operations and meet its financial obligations.
EBITDA should not be considered as an alternative to, or more meaningful
than, operating income (loss) or net income (loss) in accordance with
generally accepted accounting principals as an indicator of the Company's
operating performance or cash flow as a measure of liquidity. Additionally,
EBITDA presented may not be comparable to similarly titled measures
reported by other companies.
(e) Comparable store sales growth increase is calculated comparing net revenues
for the period to net revenues of the prior period for all stores open at
least twelve months prior to each such period.
(f) Sales per store is calculated on a monthly basis by dividing total net
revenues by the total number of stores open during the period. Annual sales
per store is the sum of the monthly calculations.
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
INTRODUCTION
Eye Care Centers of America, Inc., is the fourth largest retail optical
chain in the United States as measured by net revenues, operating 270 stores,
243 of which are optical superstores. The Company operates predominately under
the trade name "EyeMasters," and in certain geographical regions under the trade
names "Binyon's," "Visionworks," "Hour Eyes," "Dr. Bizer's VisionWorld," "Dr.
Bizer's ValuVision" and "Doctor's ValuVision". The Company operates in the $5.0
billion retail optical chain sector of the $15.4 billion optical retail market.
Management believes that key drivers of growth for retail optical chains include
(i) the aging of the United States population, (ii) the increased role of
managed vision care, (iii) the consolidation of the industry, (iv) new product
innovations and (v) the greater frequency of eyewear purchases.
In early 1996, Bernard W. Andrews joined the Company as President and Chief
Executive Officer and has built a management team with extensive operating,
merchandising and marketing experience in the optical and retail industries.
This management team has focused on improving operating efficiencies and growing
the business through both strategic acquisitions and new store openings.
The industry is highly fragmented and is undergoing significant
consolidation. See the "Industry" discussion in "ITEM 1. BUSINESS." Under the
current management team, the Company has successfully acquired and integrated
three acquisitions. In September 1996, the Company consummated the Visionworks
Acquisition, acquiring all of the outstanding shares of the capital stock of
Visionworks Holdings, Inc. for $61.5 million. At the time of the Visionworks
Acquisition, Visionworks was a sixty store optical retailer located along the
19
22
Atlantic Coast from Florida to Washington, D. C. with forty-nine superstores
and eleven optical stores located near Eckerd Corporation stores. In September
1997, the Company consummated the Hour Eyes Acquisition, acquiring all of the
outstanding capital stock of TSGI and certain assets of the PC for approximately
$22.3 million less acquisition date liabilities and simultaneously entering into
a long-term business management agreement with the PC to manage an additional
twelve Hour Eyes optical stores in Virginia. As a result of the long-term
business management agreement with Hour Eyes Doctors of Optometry, P.C., the
Company records a management fee but does not include the results of operations
from the twelve Virginia stores in the Company's consolidated results of
operations. In September 1998, the Company consummated the VisionWorld
Acquisition, acquiring certain of the assets of the Bizer entities, a nineteen
store optical retailer located primarily in Kentucky and Tennessee, for
approximately $32.2 million and simultaneously entering into a long-term
business management agreement with a private optometrist to manage the nineteen
stores. The results of operations from the date of acquisition from these
nineteen stores are included in the Company's consolidated results of
operations.
Management believes that optical retail sales through managed vision care
programs will continue to increase over the next several years. As a result,
management has made a strategic decision to pursue managed care contracts
aggressively in order to help the Company's retail business grow and over the
past three years has devoted significant management resources to the development
of its managed care business. While the average ticket price on products
purchased under managed care reimbursement plans is typically lower, managed
care transactions generally earn comparable operating profit margins as they
require less promotional spending and advertising support. The Company believes
that the increased volume resulting from managed care contracts more than
offsets the lower average ticket price. During fiscal year 1998, approximately
24% of the Company's total revenues were derived from managed care programs.
Management believes that the increasing role of managed vision care will
continue to benefit the Company and other large retail optical chains with
strong local markets shares, broad geographic coverage and sophisticated
information management and billing systems.
Historically, the Company has operated on a calendar year basis. Effective
January 1, 1994, the Company began reporting using a 52- or 53-week fiscal year
ending on the Saturday closest to December 31, with monthly results on a 4-4-5
week basis each quarter. Fiscal 1998 was a 52-week fiscal year and fiscal 1997
was a 53-week year.
On March 6, 1998, Merger Corp., THL and the Company entered into the
Recapitalization Agreement providing for, among other things, the Merger of
Merger Corp. with and into the Company. Upon consummation of the
Recapitalization on April 24, 1998, THL owned approximately 89.7% of the issued
and outstanding shares of Common Stock of the Company, existing shareholders
(including management) of the Company retained approximately 7.3% of the issued
and outstanding Common Stock and management purchased additional shares
representing approximately 3.0% of the issued and
20
23
outstanding Common Stock. The total transaction value of the Recapitalization
was approximately $323.8 million, including related fees and expenses, and the
implied total equity value of the Company following the Recapitalization is
approximately $107.3 million.
Certain of the funds needed to consummate the Recapitalization were
obtained through the sale, pursuant to rule 144A promulgated under the
Securities Act, of the Initial Notes in the aggregate principal amount of $150.0
million. The Initial Notes were issued by the Company and guaranteed by the
subsidiary guarantors. Under the Indenture governing the Initial Notes, the
Company and the subsidiary guarantors are jointly and severally liable for
payment of the Initial Notes. In addition to the net proceeds from the sale of
the Initial Notes, the Recapitalization was financed with (a) approximately
$55.0 million of borrowings under the New Credit Facility (see "Liquidity and
Capital Resources" in Management's Discussion and Analysis of Financial
Condition and Results of Operations) and (b) approximately $99.4 million from
the Equity Contribution through the sale of capital stock to THL, Bernard W.
Andrews and other members of management consisting of (i) approximately $71.6
million from the sale of Common Stock and (ii) approximately $27.8 million from
the sale of shares of New Preferred Stock. The Company used the proceeds from
such bank borrowings, the sale of the Initial Notes, and the Equity Contribution
principally to finance the conversion into cash of the shares of Common Stock
which were not retained by existing shareholders, to refinance certain existing
indebtedness of the Company, to redeem certain outstanding preferred stock of
the Company and to pay related fees and expenses of the Recapitalization. In
connection with the Recapitalization, the Company in-substance defeased its
previously issued Senior Notes by depositing with the trustee for the Senior
Notes (i) an irrevocable notice of redemption of the Senior Notes on October 1,
1998 and (ii) United States government securities in an amount necessary to
yield on October 1, 1998 $78.4 million, which constituted the principal amount,
premium and interest payable on the Senior Notes on the October 1, 1998
redemption date. The Senior Notes were defeased as scheduled on October 1, 1998.
The following is a discussion of certain factors affecting the Company's
results of operations from fiscal 1996 to fiscal 1998 and its liquidity and
capital resources. This discussion should be read in conjunction with the
consolidated financial statements and notes thereto included elsewhere in this
document.
21
24
RESULTS OF OPERATIONS
The following table sets forth the percentage relationship to net revenues
of certain income statement data.
INCOME STATEMENT DATA:
FISCAL YEAR ENDED
-------------------------------------
----- ----- -----
1996 1997 1998
----- ----- -----
Net Revenues:
Optical sales 100.0% 99.7% 98.9%
Management fee -- 0.3 1.1
----- ----- -----
Total net revenues 100.0 100.0 100.0
Operating costs and expenses:
Cost of goods sold(a) 32.8 35.2 34.3
Selling, general and administrative expenses(a) 58.1 55.0 56.3
Recapitalization and other expenses -- -- 10.8
Amortization of intangibles 1.9 1.3 1.6
----- ----- -----
Total operating costs and expenses 92.7 91.2 102.0
----- ----- -----
Income (loss) from operations 7.3 8.8 (2.0)
Interest expense, net 6.3 6.3 8.1
In-substance defeased bonds interest expense, net -- -- 1.0
----- ----- -----
Income (loss) before income taxes 1.0 2.5 (11.1)
Income tax expense (0.1) (0.1) --
----- ----- -----
Net income (loss) before extraordinary item 0.9 2.4 (11.1)
Extraordinary loss on early extinguishment of
long-term Debt -- -- 3.5
Net income (loss) 0.9 2.4 (14.6)
===== ===== =====
EBITDA margin 15.1% 15.6% 15.6%
(a) Percentages based on optical sales only
FISCAL 1998 COMPARED TO 1997
Net Revenues. The increase in net revenues to $237.9 million in 1998 from
$219.6 million in fiscal 1997 was largely the result of the Hour Eyes
Acquisition and the VisionWorld Acquisition and an increase in comparable store
sales of 1.1%. These acquisitions resulted in an increase in net revenues of
$16.7 million for fiscal 1998.
Gross Profit. Gross profit increased to $157.2 million in fiscal 1998 from
$142.5 million in fiscal 1997. Gross profit as a percentage of optical sales
increased to 65.7% ($154.6 million) in fiscal 1998 as compared to 64.8% ($141.8
million) in fiscal 1997. This percentage increase was primarily due to stores
acquired in the Hour Eyes Acquisition ("Hour Eyes Stores") which perform at a
higher margin than the stores owned by the Company prior to the Hour Eyes
Acquisition. This is primarily due to the doctor examination revenues and
expenses at the Hour Eyes Stores, which are not earned by the Company's other
locations.
Selling General & Administrative Expenses (SG&A). SG&A increased to $132.4
million in fiscal 1998 from $120.3 in fiscal 1997. SG&A as a percentage of
optical sales increased to 56.3% in fiscal 1998 from 55.0% in fiscal 1997. This
percentage increase was due primarily to
22
25
increases in operating lease expenditures and increases in overhead expenses
related to a delayed point-of-sale system implementation. These increased costs
were partially offset by savings realized through economies of scale achieved in
advertising.
Recapitalization and Other Expenses. As a result of the Recapitalization,
the Company has incurred approximately $25.1 million of non-recurring expenses.
These expenses consisted of compensation expense recorded in connection with the
exercise of employee stock options and other transaction related expenses.
Additionally, the Company incurred approximately $0.7 million in connection with
a point-of-sale system write-off.
Amortization Expense. Amortization expense (excluding the amortization of
store pre-opening costs) increased to $3.7 million for fiscal 1998 from $2.9
million in fiscal 1997. This increase was due to amortization of the goodwill
related to the Hour Eyes Acquisition and the VisionWorld Acquisition, which were
recorded during the fourth quarter of fiscal 1997 and fiscal 1998, respectively.
Net Interest Expense. Net interest expense increased to $19.2 million for
fiscal 1998 from $13.7 million for fiscal 1997. This increase was due to the
increased borrowings made in connection to the Recapitalization but is partially
offset by reduced rates on the new debt issued in the Recapitalization.
In-substance Defeased Bonds Net Interest Expense. Net interest expense
related to the in-substance defeased bonds was $2.4 million in 1998 and reflects
the net amount of interest expense related to the in-substance defeased bonds
and the interest income related to the investment securities-restricted from
April 24, 1998 (date the bonds were in-substance defeased) until the defeasement
on October 1, 1998.
Extraordinary Item. An extraordinary loss of $8.4 million that was due to
the write-off of deferred financing fees related to the early extinguishment of
debt and to the call premiums on the Senior Notes was incurred during fiscal
1998.
1997 COMPARED TO 1996
Net Revenues. The increase in net revenues of 38.8% to $219.6 million in
fiscal 1997 from $158.2 million in fiscal 1996 was primarily the result of the
$52.2 million in sales attributable to a full year of Visionworks stores and
three months of Hour Eyes stores in the Company's fiscal 1997 results and an
increase in comparable store sales of 3.8% in fiscal 1997. In addition, fiscal
1997 was a fifty-three week year and fiscal 1996 was a fifty-two week year.
Gross Profit. Gross profit as a percentage of net revenues decreased by 3.4%
to 64.9% in fiscal 1997 as compared to 67.2% in fiscal 1996. Gross profit was
$142.5 million in fiscal 1997 compared to $106.3 million in fiscal 1996. This
percentage decrease was primarily due to the inclusion of a complete year of the
Visionworks stores in the Company's fiscal 1997 results. Visionworks stores
operate at a lower gross margin primarily due to the sale of contact lenses,
which have lower gross margins and are not sold at a majority of the Company's
other locations.
23
26
Selling, General and Administrative Expenses. SG&A increased by 30.9% to
$120.3 million in fiscal 1997 as compared to fiscal 1996. SG&A as a percentage
of net revenues decreased by 5.7% to 54.8% in fiscal 1997 from 58.1% for the
same period of fiscal 1996. This percentage decrease was due primarily to
savings realized through more efficient payroll management and increased
leveraging of advertising expenditures due to the inclusion of a complete year
of the Visionworks stores in the Company's fiscal 1997 results.
Amortization Expense. Amortization expense (excluding the amortization of
store pre-opening costs) remained at $2.9 million in fiscal 1997.
Net Interest Expense. Net interest expense in fiscal 1997 increased by 38.4%
to $13.7 million as compared to $9.9 million in fiscal 1996. This increase was
due to the interest expense associated with the $49.0 million which the Company
borrowed to consummate the Visionworks Acquisition and the Hour Eyes Acquisition
and the interest on the $10.0 million capital lease which the Company assumed as
a result of the Visionworks Acquisition.
SYSTEMS CONVERSION; YEAR 2000 ISSUE
The Company is aware of the potential for industry wide business
disruption which could occur due to problems related the "Year 2000 issue." It
is the belief of the Company's management that it has a prudent plan in place to
address these issues within the Company and with its suppliers. The components
of the Company's plan include: an assessment of internal systems for
modification and/or replacement; communication with external vendors to
determine their state of readiness to maintain an uninterrupted supply of goods
and services to the Company; an evaluation of the Company's production equipment
as to its ability to function properly after the turn of the century; an
evaluation of facility related issues; the retention of technical and advisory
expertise to ensure that the Company is taking prudent action steps; and the
development of a contingency plan.
State of Readiness
The Company has developed a comprehensive plan to reduce the
probability of operational difficulties due to Year 2000 related failures. While
there is still a significant amount of work to do, the Company believes that it
is on track towards a timely completion in the fall of 1999. Overall the Company
estimates that it has completed approximately 80% of the Year 2000 issue
identification process, approximately 50% of the process of remediating year
2000 issues that have been identified to date.
Internal Systems (Information Technology)
To date, the Company has fully completed its assessment of all
information technology systems that could be significantly affected by the Year
2000 issue. The completed assessment indicated that certain systems are already
Year 2000 compliant while others are still in the process of being remediated.
Compliant systems include the Company's general ledger system
24
27
and the Company's point-of-sale system. Systems that are in the process of being
remediated are the payroll/human resources system and the merchandising system
both of which should be compliant by the summer of 1999.
Suppliers
The Company is in the process of communicating with its external
vendors to gain an understanding of their state of readiness to maintain an
uninterrupted supply of goods and services to the Company. Although the Company
believes that its products may be purchased from a number of vendors on
comparable terms and that therefore it is not dependent on any vendors or any
other single vendor for frames or lenses, the Company has identified vendors
that may otherwise be viewed as critical to its business. The Company is
defining a critical vendor as one who's inability to continue to provide goods
and services would have a serious adverse impact on the Company's ability to
produce, deliver, and collect payment for eyewear and/or services. To date the
Company is not aware of any supplier with a Year 2000 issue that would
materially impact the results of operations, liquidity or capital resources.
However the Company has no means of ensuring that suppliers will be Year 2000
ready. The inability of suppliers to complete their Year 2000 resolution process
in a timely fashion could materially impact the Company.
Production Equipment
The Company has completed an inventory of production equipment
currently used at the Company. The Company has determined the Year 2000
readiness of this equipment through communication with the equipment
manufacturers and testing where appropriate. The Company is not aware of any
production equipment that is affected by the Year 2000 issue.
Facility Related Issues
The Company is in the process of evaluating facilities related
equipment with the potential for Year 2000 related failures. The Company will
determine the Year 2000 readiness of this equipment through communication with
the equipment manufacturers and testing where appropriate. It is the Company's
intention to repair or replace non-compliant equipment prior to operating
difficulties. The Company, as in most companies, remains aware of the potential
for imbedded logic within microchips to cause equipment failure. The Company
believes that it has a prudent approach towards evaluating facilities equipment,
however, it may be impracticable or impossible to test certain items of
equipment for Year 2000 readiness. To the extent such untested equipment is not
Year 2000 ready, it may fail to operate on January 1, 2000, resulting in
possible interruptions of security, heating, elevator, telephone and other
services.
Technical and Advisory Expertise
The Company has engaged outside consultants to assist it in project
planning, testing methodologies, and evaluating our Year 2000 remediation
activities.
25
28
Costs
The Company is evaluating the total cost of Year 2000 compliance. At
this time, the Company estimates the total cost of Year 2000 related activities
to be approximately $650,000, with $300,000 of that amount yet to be incurred.
This amount is incremental spending and has been budgeted within the normal
magnitude of Information Technology spending. This amount includes the
replacement of hardware and applications that are outdated and were due for
replacement regardless of Year 2000 issues.
Contingency Plan
Although the Company believes that it is taking prudent action related
to the identification and resolution of issues related to the Year 2000 its
assessment is still in progress. The Company may never be able to know with
certainty whether certain key vendors are compliant. Failure of key vendors to
make their computer systems Year 2000 compliant could result in delayed
deliveries of products to the Company. If such delays are extended they could
have a material adverse effect on the Company's business, financial condition,
and results of operations. There are also technical vagaries to logic imbedded
within microchips, which may prove impracticable or impossible to test. To the
extent such microchips are not Year 2000 compliant, this could have a material
adverse effect on the Company's business, financial condition, and results of
operations.
The Company continues to evaluate the risks associated with potential
Year 2000 related failures. As it better understands the risks within its unique
set of business partners, production processes, and internal systems, it will
develop a formal contingency plan to alleviate the impact of high potential or
serious failures. The Company anticipates having this contingency plan outlined
by March 1999. Until the contingency plan is completed, the Company does not
possess the information necessary to estimate the potential impact of Year 2000
compliance issues relating to its IT systems, non-IT systems, its vendors, its
customers, and other parties.
Risks
The failure to correct a material Year 2000 problem could result in an
interruption in, or a failure of, certain normal business activities or
operations. Such failures could materially and adversely affect the Company's
results of operations, liquidity and financial condition. Due to the general
uncertainty inherent in the Year 2000 problem, resulting in part from the
uncertainty of the Year 2000 readiness of third-party suppliers, the Company is
unable to determine at this time whether the consequences of Year 2000 failures
will have a material impact on the Company's results of operations, liquidity or
financial condition. The Company's efforts related to the Year 2000 issue is
expected to significantly reduce the Company's level of uncertainty about the
Year 2000 problem and, in particular, about the Year 2000 compliance and
readiness of its critical vendors. The Company believes that, with the
implementation of new business systems and completion of the plans set in place
related to the Year 2000 issue, the possibility of significant interruptions of
normal operations should be reduced.
26
29
LIQUIDITY AND CAPITAL RESOURCES
Cash flows from operating activities provided net cash for 1998, 1997 and
1996 of $0.2 million, $15.5 million and $14.0 million, respectively. As of
January 2, 1999, the Company had $5.1 million of cash available to meet the
Company's obligations.
Capital expenditures for 1998, 1997 and 1996 were $20.7 million, $9.5
million and $4.2 million respectively. Capital expenditures for 1999 are
projected to be approximately $15 to $17 million. Capital expenditures are
related to the construction of new stores, repositioning of existing stores in
some markets and new computer systems for the stores. These capital expenditures
include leasehold improvements, laboratory, equipment, furniture and fixtures,
doctors' equipment, point-of-sale equipment, and computer hardware and software.
On April 24, 1998, the Company entered into a credit agreement (the "New
Credit Facility") which consists of (i) the $55.0 million term loan facility
(the "Term Loan Facility"); (ii) the $35.0 million revolving credit facility
(the "Revolving Credit Facility"); and (iii) the $100.0 million acquisition
facility (the "Acquisition Facility"), of which $50.0 million was committed at
April 24, 1998. The proceeds of the "New Credit Facility" were used to pay long
term debt outstanding under the previous credit facility. At January 2, 1999,
the Company had $55.0 million in term loans outstanding under the Term Loan
Facility and $30.1 million outstanding under the Acquisition Facility which
funded the VisionWorld Acquisition. Approximately $10.0 million of the Revolving
Credit Facility is restricted for the repayment of the capital lease obligation
to Eckerd Corporation. Borrowings made under the New Credit Facility bear
interest at a rate equal to, at the Company's option, LIBOR plus 2.25% or the
Base Rate (as defined in the New Credit Facility) plus 1.25%. The Term Loan
Facility matures five years from the closing date of the New Credit Facility and
will amortize quarterly in aggregate annual principal amounts of approximately
$0.0 million, $4.0 million, $12.0 million, $18.0 million, and $21.0 million,
respectively, for years one through five after April 24, 1998.
In connection with the Recapitalization, the Company in-substance defeased
its previously issued Senior Notes by depositing with the trustee for the Senior
Notes (i) an irrevocable notice of redemption of the Senior Notes on October 1,
1998 and (ii) United States government securities in an amount necessary to
yield on October 1, 1998 $78.4 million, which constitutes the principal amount,
premium and interest payable on the Senior Notes on the October 1, 1998
redemption date. On October 1, 1998, the Senior Notes were defeased as scheduled
and the Company recorded an extraordinary charge of $4.2 million on the
statement of operations for defeasance costs during the third quarter related to
the call premium on the bonds.
In connection with the Recapitalization, the Company completed a debt
offering of the Initial Notes, consisting of the Fixed Rate Notes and the
Floating Rate Notes. Interest on the Initial Notes will be payable semiannually
on each May 1
27
30
and November 1, commencing on November 1, 1998. Interest on the Fixed Rate Notes
accrues at the rate of 9 1/8% per annum. The Floating Rate Notes bear interest
at a rate per annum, reset semiannually, and equal to LIBOR (as defined in the
Indenture) plus 3.98%. The Initial Notes will not be entitled to the benefit of
any mandatory sinking fund. For discussion of restrictions on subsidiaries, see
Note 8 to the January 2, 1999 Consolidated Financial Statements. On April 24,
1998, the Company entered into an interest rate swap agreement that converts a
portion of the Floating Rate Notes to a fixed rate.
The Company filed a registration statement with the Securities and
Exchange Commission with respect to an offer to exchange the Initial Notes for
notes which have terms substantially identical in all material respects to the
Initial Notes, except such notes are freely transferable by the holders thereof
and are issued without any covenant regarding registration (the "Exchange
Notes"). The registration statement was declared effective on January 28, 1999.
The exchange period ended March 4, 1999. The Exchange Notes are the only notes
of the Company which are currently outstanding.
During 1996, the Company issued 110,000 shares of Series A Cumulative
Mandatorily Redeemable Exchangeable Pay-in-Kind Preferred Stock ("Preferred
Stock"). In conjunction with the Recapitalization, the Company repurchased the
Preferred Stock, canceled it and issued 300,000 shares of a new series of
preferred stock (the "New Preferred Stock"), par value $ .01 per share.
Dividends on shares of New Preferred Stock are cumulative from the date of issue
(whether or not declared) and will be payable when and as may be declared from
time to time by the Board of Directors of the Company. Such dividends accrue on
a daily basis from the original date of issue at an annual rate per share equal
to 13% of the original purchase price per share, with such amount to be
compounded quarterly. The New Preferred Stock will be redeemable at the option
of the Company, in whole or in part, at $100 per share plus (i) the per share
dividend rate and (ii) all accumulated and unpaid dividends, if any, to the date
of redemption, upon occurrence of an offering of equity securities, a change of
control or certain sales of assets.
In connection with the Visionworks Acquisition, the Company assumed an
agreement to sublease land, buildings and equipment at eight operating
locations. Under the terms of the agreement, the Company committed to purchase
such properties for $10.0 million and to pay Eckerd Corporation an annual rent
of $1.3 million for the subleases.
The Company anticipates that cash from operations and funds available under
the Revolving Credit Facility will be sufficient to finance the Company's
continuing operations and to make all required payments of principal and
interest on the Exchange Notes through the next twelve months.
In August 1997, the Company sold, for net proceeds of $4.8 million, the
building in which its corporate headquarters is located. The Company entered
into a 15 year operating lease with the new owners and will maintain its current
location. As a result of this transaction, the Company recorded a deferred gain,
which will be amortized over the life of the lease.
INFLATION
The impact of inflation on the Company's operations has not been
significant to date. While the Company does not believe its business is highly
sensitive to inflation, there can be no assurance that a high rate of inflation
would not have an adverse impact on the Company's operations.
SEASONALITY AND QUARTERLY RESULTS
The Company's sales fluctuate seasonally. Historically, the Company's
highest sales and earnings occur in the first and third quarters. In addition,
quarterly results are affected by the opening of new stores; therefore, the
Company's growth, the Visionworks Acquisition, the Hour Eyes
28
31
Acquisition and the VisionWorld Acquisition may affect seasonal fluctuations.
Hence, quarterly results are not necessarily indicative of results for the
entire year.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
The Company is exposed to various market risks. Market risk is the potential
loss arising from adverse changes in market prices and rates. The Company does
not enter into derivative or other financial instruments for trading or
speculative purposes.
INTEREST RATE RISK
The Company's primary market risk exposure is interest rate risk, with
specific vulnerability to changes in LIBOR. At January 2, 1999, $130.1 million
of the Company's long-term debt bears interest at variable rates, with $100.0
million of that amount effectively converted to fixed rates through interest
rate swap agreements. Accordingly, the Company's net income is affected by
changes in interest rates. Assuming a two hundred basis point change in the 1998
average interest rate under the $30.1 million in unhedged borrowings, the
Company's 1998 interest expense would have changed approximately $600,000.
At January 2, 1999, the Company had an unrealized loss of $1.2 million
related to the $100.0 million swap portfolio. The Company's fixed pay rate is
5.9% while the floating receive rate is based on LIBOR, 5.0% at end of fiscal
1998. A two hundred basis point change in the receive rate would affect the
Company's position by $2.0 million.
In the event of an adverse change in interest rates, management could take
actions to mitigate its exposure. However, due to the uncertainty of the actions
that would be taken and their possible effects, this analysis assumes no such
actions. Further, this analysis does not consider the effects of the change in
the level of overall economic activity that could exist in such an environment.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The financial statements and supplementary data are set forth in this
annual report on Form 10-K commencing on page F-1.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE
None.
29
32
PART III
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
The table below sets forth the names, ages and positions of the executive
officers and directors of the Company.
NAME AGE POSITION
- ---- --- --------
Bernard W. Andrews 57 Chairman and Chief Executive Officer
David E. McComas 56 President and Chief Operating Officer
Alan E. Wiley 52 Executive Vice President, Chief Financial Officer, Secretary and Treasurer
George E. Gebhardt 48 Executive Vice President of Merchandising and Managed Vision Care
Michele M. Benoit 42 Senior Vice President of Human Resources
Charles A. Brizius 30 Director
Anthony J. DiNovi 36 Director
Norman S. Matthews 65 Director
Warren C. Smith, Jr. 42 Director
Antoine G. Treuille 49 Director
Directors of the Company are elected at the annual shareholders' meeting
and hold office until their successors have been elected and qualified. The
officers of the Company are chosen by the Board of Directors and hold office
until they resign or are removed by the Board of Directors.
Bernard W. Andrews has been Chairman of the Company since the consummation
of the Recapitalization. Mr. Andrews joined the Company as Director and Chief
Executive Officer in March 1996. From January 1994 to April 1995, Mr. Andrews
was President and Chief Operating Officer, as well as a Director of Montgomery
Ward-Retail. He was an Executive Vice President and a Director of Circuit City
Stores, Inc., from October 1983 to May 1990, serving as President-Hardlines,
Executive Vice President-Marketing and Vice President-Home Fashions. Prior to
that, Mr. Andrews spent twenty years with Sears, Roebuck & Co. in a number of
merchandising, marketing and operating positions.
David E. McComas has served as the President and Chief Operating Officer of
the Company since July 1998. Prior to that, Mr. McComas was Western Region
President and Corporate Vice President, Circuit City Stores, Inc., responsible
for eight Western States and Hawaii since 1994. Prior to 1994, Mr. McComas was
General Manager of Circuit City Stores, Inc. Mr. McComas has over thirty years
of store management experience including stints at Montgomery Ward Holding
Corporation and Sears, Roebuck & Co.
Alan E. Wiley has served as Executive Vice President and Chief Financial
Officer of the Company since November 1998. Prior to that, since 1992, Mr. Wiley
served as the Senior Executive Vice President, Secretary, Chief Financial and
Administrative Officer and a Director of The Cato Corporation. From 1981 through
1990, Mr. Wiley held senior administrative and financial positions with British
American Tobacco, U.S. in various companies of the specialty retail division.
30
33
George E. Gebhardt has served as the Company's Executive Vice President of
Merchandising, since September 1996 when the Company purchased his former
employer, Visionworks, and Managed Vision Care since February 1999. Mr. Gebhardt
was with Visionworks from February 1994 to September 1996 serving in various
positions, most recently Senior Vice President of Merchandising and Marketing.
Prior to that, Mr. Gebhardt spent over thirteen years with Eckerd Corporation in
various operational positions including Senior Vice President, General Manager
of Eckerd Vision Group. Mr. Gebhardt also spent seven years working for Procter
& Gamble serving in various positions including Unit Sales Manager of Procter &
Gamble's Health and Beauty Care Division.
Michele M. Benoit has served as the Company's Senior Vice President of
Human Resources since April 1997. From 1995 until joining the Company, she was
Vice President, Human Resources for Ben Franklin Retail Stores, Inc. Prior to
that, Ms. Benoit was a Vice President and Managing Director with Kennedy and
Company, a retail executive search firm based in Chicago, Illinois. She also
spent fourteen years with Montgomery Ward and Company where she held a variety
of human resources and operational positions.
Norman S. Matthews has served as a Director of the Company since October
1993 and served as Chairman from December 1996 to April 1998. Mr. Matthews is
Chairman of the Executive Committee of the Company's Board of Directors. From
1988 to the present, Mr. Matthews has been an independent retail consultant and
venture capitalist. Mr. Matthews was President of Federated Department Stores
from 1987 to 1988, and served as Vice Chairman from 1983 to 1987. He is also a
Director of Finlay Fine Jewelry Corporation, Toys "R" Us, Inc., The Progressive
Corporation, Loehmann's, Inc. and Lechters, Inc.
Antoine G. Treuille has served as a Director of the Company since October
1993. In March 1998, Mr. Treuille became Managing Director of Financo, Inc., an
investment bank. Mr. Treuille has served as President of Charter Pacific Corp.
since May 1996. Prior to his current position, Mr. Treuille served as Senior
Vice President of DCMI. From September 1985 to April 1992, he served as
Executive Vice President with the investment firm of Entrecanales, Inc. Mr.
Treuille also serves as a Director of Societe BIC S.A. and Special Metals Corp.
Anthony J. DiNovi has served as a Director of the Company since the
consummation of the Recapitalization. Mr. DiNovi has been employed by Thomas H.
Lee Company since 1988 and currently serves as a Managing Director. Mr. DiNovi
is a Managing Director and Member of THL Equity Advisors IV, LLC, the general
partner of Thomas H. Lee Equity Fundy IV, LP and Vice President of Thomas H. Lee
Advisors I and T.H. Lee Mezzanine II, affiliates of ML-Lee Acquisition Fund
L.P., ML-Lee Acquisition Fund II, L.P. and ML-Lee Acquisition fund II
(Retirement Accounts), L.P., respectively. Mr. DiNovi also serves as a Director
of Safelite Glass Corp., The Learning Company, Inc. and Fisher Scientific
International, Inc.
Warren C. Smith, Jr., has served as a Director of the Company since the
consummation of the Recapitalization. Mr. Smith has been employed by Thomas H.
Lee Company since 1990 and currently serves as a Managing Director. Mr. Smith is
a Managing Director and Member of THL Equity Advisors IV, LLC, the general
partner of Thomas H. Lee Equity Fund IV, LP and Vice President of Thomas H. Lee
Advisors I and T.H. Lee Mezzanine II, affiliates of ML-Lee Acquisition Fund,
L.P., ML-Lee Acquisition Fund II, L.P. and ML-Lee Acquisition Fund II
(Retirement Accounts), L.P., respectively. Mr. Smith also serves as a Director
of Rayovac Corporation, Finlay Fine Jewelry Corporation and Just For Feet, Inc.
Charles A. Brizius has served as a Director of the Company since the
consummation of the Recapitalization. Mr. Brizius worked as Thomas H. Lee
Company from 1993 to 1995, rejoined in 1997 and currently serves as an
Associate. Mr. Brizius is a Member of THL Equity Advisors IV, LLC, the general
partner of Thomas H. Lee Equity Fund IV, LP. From 1991 to 1993, Mr. Brizius
worked as Morgan Stanley & Co. Incorporated in the Corporate Finance Department.
31
34
ITEM 11. EXECUTIVE COMPENSATION
The following table sets forth certain information concerning the
compensation paid during the last three years to the Company's Chief Executive
Officer during fiscal 1998 and the four other most highly compensated executive
officers serving as executive officers at the end of fiscal 1998 (the "Named
Executive Officers").
SUMMARY COMPENSATION TABLE
LONG-TERM
COMPENSATION
ANNUAL --------------
COMPENSATION AWARDS
-------------------------------------------- --------------
OTHER ANNUAL SECURITIES ALL OTHER
COMPENSATION UNDERLYING COMPENSATION
NAME AND PRINCIPAL POSITION YEAR SALARY($)(a) BONUS($)(b) ($)(c) OPTIONS(#) ($)(d)
- --------------------------- ---- ------------ ----------- ------------- -------------- ------------
Bernard W. Andrews 1998 489,480 -- -- 371,376 8,663,996
Chairman and Chief 1997 398,567 -- -- -- 4,591
Executive Officer 1996 289,902 325,000 137,439 75,000 4,200
David E. McComas 1998 153,750 500,000 -- 120,000 --
President and Chief 1997 -- -- -- -- --
Operating Officer 1996 -- -- -- -- --
George E. Gebhardt 1998 205,577 -- -- 35,000 790,175
Executive Vice President 1997 188,231 -- 49,166 -- --
of Merchandising, 1996 39,846 17,444 -- 13,000 --
Construction And Design
William Shertzer (e) 1998 158,385 -- -- 30,000 1,459,678
Senior Vice President of 1997 144,846 -- -- -- --
Managed Vision Care 1996 139,039 58,441 -- 10,000 894
Michele Benoit 1998 143,673 -- -- 25,000 384,379
Senior Vice President of 1997 81,731 25,000 55,798 7,000 --
Human Resources 1996 -- -- -- -- --
- ------------
(a) Represents annual salary, including any compensation deferred by the
Named Executive Officer pursuant to the Company's 401(k) defined
contribution plan or the Company's deferred stock plan.
(b) Represents annual bonus earned by the Named Executive Officer for the
relevant fiscal year.
(c) Except with respect to Mr. George E. Gebhardt and Ms. Michele Benoit for
1997 and Mr. Bernard W. Andrews for 1996, the dollar value of the
perquisites and other personal benefits, securities or property paid to
each Named Executive Officer did not exceed the lesser of $50,000 or 10%
of reported annual salary and bonus received by the Named Executive
Officer. Of the total other annual compensation received by Mr. Gebhardt
in 1997, $41,966 related to relocation expenses paid by the Company on
behalf of Mr. Gebhardt. Of the total other annual compensation received
by Ms. Benoit in 1997, $51,090 related to relocation expenses paid by the
Company on behalf of Ms. Benoit. Of the total other annual compensation
received by Mr. Andrews in 1996, $131,861 related to relocation expenses
paid by the Company on behalf of Mr. Andrews.
(d) In connection with the Recapitalization, all outstanding options were
simultaneously vested and exercised. Except with respect to Mr. Bernard
W. Andrews' term life insurance premiums discussed below, all 1998
amounts represent the compensation amounts related to the exercise of
options. During 1998, 1997 and 1996, the Company paid $4,893, $4,591 and
$4,200, respectively, for premiums for term life insurance for Mr.
Andrews. The remaining 1996 amount in this column relates to
contributions made by the Company to the Company's 401(k) defined
contribution plan on behalf of the respective Named Executive Officer.
(e) William Shertzer resigned from the Company effective February 26, 1999.
32
35
STOCK OPTION GRANTS. The following table sets forth information with
respect to the Named Executive Officers concerning options granted during fiscal
1998. The Named Executive Officers have not been granted any SARs.
INDIVIDUAL GRANTS POTENTIAL REALIZED VALUE AT
NUMBER OF ------------------------------ ASSUMED ANNUAL RATES OF
SECURITIES % OF TOTAL EXERCISE STOCK PRICE APPRECIATION
UNDERLYING OPTIONS GRANTED OR BASE FOR OPTION TERM
OPTIONS TO EMPLOYEES IN PRICE EXPIRATION -------------------------------
NAME GRANTED (#) FISCAL YEAR ($/SH) DATE 5% 10%
- ---- ----------- --------------- -------- ---- -- ---
Bernard W. Andrews 371,376 43.5% $ 10.41 7/08 $ 5,997,472 $ 9,115,883
David E. McComas 120,000 14.1% $ 10.41 7/08 $ 1,937,919 $ 2,945,548
George E. Gebhardt 35,000 4.1% $ 10.41 7/08 $ 565,226 $ 859,118
William Shertzer 30,000 3.5% $ 10.41 7/08 $ 484,480 $ 736,387
Michele Benoit 25,000 2.9% $ 10.41 7/08 $ 403,733 $ 613,656
STOCK OPTION EXERCISES AND HOLDINGS TABLE. The following table sets forth
information with respect to the Named Executive Officers concerning unexercised
options held as of January 2, 1999. The Named Executive Officers have not been
granted any SARs.
AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND FY-END OPTION VALUES
NUMBER OF
SECURITIES VALUE OF
UNDERLYING UNEXERCISED
UNEXERCISED IN-THE-MONEY
OPTIONS OPTIONS
AT FY-END (#) AT FY-END ($)
SHARES VALUED ---------------- ----------------
ACQUIRED ON REALIZED EXERCISABLE/ EXERCISABLE/
NAME EXERCISE(#)(a) ($)(c) UNEXERCISABLE UNEXERCISABLE(b)
- ---- -------------- --------- ---------------- ----------------
Bernard W. Andrews 75,000 $ 8,205,796 -/371,376 --
David E. McComas -- -- -/120,000 --
George E. Gebhardt 13,000 $ 778,846 -/35,000 --
William Shertzer 13,292 $ 1,248,268 -/30,000 --
Michele Benoit 7,000 $ 384,379 -/25,000 --
(a) Exercise occurred prior to Recapitalization and therefore number of
shares does not reflect 12 for 1 stock split.
(b) There is currently no active trading market for the Common Stock and thus
the fair market value as of January 2, 1999 is not determinable.
(c) Value realized is the difference between the recapitalization option
price per share and the option exercise price.
33
36
COMMITTEES OF THE BOARD OF DIRECTORS
The Board of Directors has an Executive Committee of which Norman S.
Matthews is chairman and, as of the date hereof, the sole member.
The Board of Directors has a Compensation Committee currently consisting of
Messrs. Matthews, DiNovi and Smith. The Compensation Committee makes
recommendations concerning the salaries and incentive compensation of employees
of and consultants to the Company.
The Board of Directors has an Audit Committee currently consisting of
Messrs. DiNovi, Smith, Treuille and Brizius. The Audit Committee is responsible
for reviewing the results and scope of audits and other services provided by the
Company's independent auditors.
DIRECTOR COMPENSATION
The Company may compensate its directors for services rendered in such
capacity.
The Company entered into a three year consulting agreement (the "Consulting
Agreement"), effective as of the closing of the Recapitalization, with Norman S.
Matthews, which provides for the payment of an annual consulting fee of $50,000.
The Consulting Agreement provides for the grant to Mr. Matthews, concurrently
with the closing of the Recapitalization, of an option to purchase up to 1.5% of
the fully diluted Common Stock or approximately 110,000 shares as of the closing
of the Recapitalization, subject to a vesting schedule which will be one-half
time based and one-half performance based, at an exercise price equal to
approximately $10.41 per share, the same price paid by THL in connection with
the Recapitalization.
EMPLOYMENT AGREEMENT
Bernard W. Andrews entered into an employment agreement with the Company,
effective as of the closing of the Recapitalization, which provides for his
employment with the Company for an initial term of three years, and will
thereafter be renewed for consecutive one year terms unless terminated by either
party. Mr. Andrews is entitled to a base salary of $500,000 during the first
year following the Recapitalization, $550,000 during the second year and
$600,000 during the third year. Mr. Andrews will be eligible to receive an
annual performance bonus upon the achievement by the Company of certain EBITDA
targets as determined from year to year by the Board of Directors.
Under the terms of his employment agreement, Mr. Andrews purchased $1.0
million of Common Stock at the same price that THL paid in connection with the
Recapitalization. Mr. Andrews paid for these shares by delivering a promissory
note with an original purchase amount of $1.0 million, which shall accrue
interest at a fixed rate equal to the Company's initial borrowing rate. The
repayment of such note is secured by Mr. Andrews' shares of Common Stock.
34
37
Mr. Andrews is entitled to receive severance of two times his base salary
upon termination by the Company without cause or by Mr. Andrews for good reason.
Severance shall be paid over twelve months. Mr. Andrews also will be subject to
a standard restrictive covenants agreement (including non-competition,
non-solicitation, and non-disclosure covenants) during the term of his
employment and for a period of three years following termination for any reason.
Mr. Andrews has received non-qualified options to purchase 371,376 shares of
Common Stock. Certain of these options vest over time and others vest upon the
Company reaching certain profitability levels. If the profitability levels are
not reached for a given year, the options fail to become exercisable and are
carried forward to the next succeeding vesting period.
STOCK OPTION PLAN
The Company has granted stock options to certain officers under the
Company's 1998 stock option plan. As of March 23, 1999, options to purchase
411,500 shares of Common Stock were outstanding. Subject to acceleration under
certain circumstances, the options vest over a four-year period. The per option
exercise price is $10.41. Generally, all unvested options will be forfeited upon
termination of employment.
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION. During 1998,
the Compensation Committee consisted of Messrs. Matthews, DiNovi and Smith, none
of whom were an officer or employee of the Company.
35
38
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
The following table sets forth information with respect to the
anticipated beneficial ownership of shares of the Common Stock as of March 23,
1999 by persons who are beneficial owners of more than 5% of the common stock,
by each director, by each Named Executive Officer of the Company and by all
directors and executive officers as a group, as determined in accordance with
Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange
Act"). All shares of the Common Stock are voting stock.
Shares of Percentage
Name of Beneficial Owner(a) Common Stock of Class
Thomas H. Lee Equity Fund IV, L.P. (and affiliates of THL Co.)(b) ......... 6,664,800 89.9%
Equity-Linked Investors-II (c) ............................................ 383,616 5.2
Bernard W. Andrews (e) .................................................... 254,016 3.4
David E. McComas (f) ...................................................... 24,015 *
Norman S. Matthews (g) .................................................... 19,692 *
Antoine G. Treuille (h) ................................................... 6,528 *
George E. Gebhardt (i) .................................................... 19,212 *
Michele Benoit (j) ........................................................ 9,600 *
Anthony J. DiNovi (b) ..................................................... 6,664,800 89.9
Warren C. Smith (b) ....................................................... 6,664,800 89.9
Charles A. Brizius (b) .................................................... 6,664,800 89.9
All directors and executive officers of the Company as a group (11)(d) .... 7,017,075 93.9
- ----------
* Less than 1%.
(a) Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission and reflects general voting power
and/or investment power with respect to securities.
(b) The business address for such person(s) is c/o Thomas H. Lee Company, 75
State Street, Suite 2600, Boston, Massachusetts 02109. All such voting
securities may be deemed to be beneficially owned by THL Equity Advisors
IV, LLC ("Advisors"), the general partner of THL Fund IV, Thomas H. Lee,
Messrs. DiNovi, Smith and the other managing directors and by Mr.
Brizius and the other officers of THL Co., in each case pursuant to the
definition of beneficial ownership provided in footnote (a). Each of
such persons disclaims beneficial ownership of such shares.
(c) Equity-Linked Investors-II is an investment partnership managed by Desai
Capital Management Incorporated. The business address for such person is
c/o Desai Capital Management Incorporated, 540 Madison Avenue, New York,
New York 10022.
(d) Includes 6,664,800 shares beneficially owned by THL described in
footnote (b).
(e) Includes 61,896 shares issuable pursuant to presently exercisable
options (or those exercisable prior to May 22, 1999). Excludes 309,480
shares issuable pursuant to options which are not currently exercisable
(or exercisable prior to May 22, 1999).
36
39
(f) Excludes 120,000 shares issuable pursuant to options which are not
currently exercisable (or exercisable prior to May 22, 1999).
(g) Excludes 111,412 shares issuable pursuant to options which are not
currently exercisable (or exercisable prior to May 22, 1999).
(h) Excludes 5,000 shares issuable pursuant to options which are not
currently exercisable (or exercisable prior to May 22, 1999).
(i) Excludes 35,000 shares issuable pursuant to options which are not
currently exercisable (or exercisable prior to May 22, 1999).
(j) Excludes 25,000 shares issuable pursuant to options which are not
currently exercisable (or exercisable prior to May 22, 1999).
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
MANAGEMENT AGREEMENT
The Company and THL Co. entered into a management agreement as of the
closing date of the Recapitalization (the "Management Agreement"), pursuant to
which THL Co. received a financial advisory fee of $6.0 million in connection
with structuring, negotiating and arranging the Recapitalization and
structuring, negotiating and arranging the debt financing. In addition, pursuant
to the Management Agreement, THL Co. initially receives $500,000 per year plus
expenses for management and other consulting services provided to the Company,
including one percent (1%) of the gross purchase price for acquisitions for its
participation in the negotiation and consummation of any such acquisition. The
Management Agreement continues unless and until terminated by mutual consent of
the parties in writing, for so long as THL Co. provides management and other
consulting services to the Company. The Company believes that the terms of the
Management Agreement are comparable to those that would have been obtained from
unaffiliated sources.
STOCKHOLDERS' AGREEMENT
The Company entered into a Stockholders' Agreement (the "Stockholders'
Agreement") among THL and the other shareholders of the Company upon the
consummation of the Recapitalization. Pursuant to the Stockholders' Agreement,
the shareholders are required to vote their shares of capital stock of the
Company to elect a Board of Directors of the Company consisting of directors
designated by THL. The Stockholders' Agreement also grants THL the right to
require the Company to effect the registration of shares of Common Stock they
hold for sale to the public, subject to certain conditions and limitations. If
the Company proposes to register any of its securities under the Securities Act
of 1933, as amended, whether for its own account or otherwise, the shareholders
are entitled to notice of such registration and are entitled to include their
shares in such registration, subject to certain conditions and limitations. All
fees, costs and expenses of any registration effected on behalf of such
shareholders under the Stockholders' Agreement (other than underwriting
discounts and commissions) will be paid by the Company.
37
40
PART IV
ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K
(a) The following documents are filed as part of this report.
Page of 10-K
------------
1. FINANCIAL STATEMENTS
Report of Independent Auditors F-2
Consolidated Balance Sheets at January 3, 1998 and January 2, 1999 F-3
Consolidated Statements of Operations for the Years Ended December 28, 1996,
January 3, 1998 and January 2, 1999 F-4
Consolidated Statements of Shareholders' Equity/(Deficit) at December 28,
1996, January 3, 1998 and January 2, 1999 F-5
Consolidated Statements of Cash Flows at December 28, 1996, January 3, 1998
and January 2, 1999 F-6
Notes to the Consolidated Financial Statements F-8
2. FINANCIAL STATEMENT SCHEDULES
Schedule II - Consolidated Valuation and Qualifying Accounts - for the Years
Ended December 28, 1996, January 3, 1998 and January 2, 1999 F-37
3. EXHIBITS
2.1 Stock Purchase Agreement dated August 15, 1996 by and
between Eye Care Centers of America, Inc., Visionworks
Holdings, Inc. and the Sellers listed therein. (a)
2.2 Stock Purchase Agreement, dated September 30 1997, by
and among Eye Care Centers of America, Inc., a Texas
corporation, Robert A. Samit, O. D. and Michael
Davidson, O. D. (a)
2.3 Recapitalization Agreement dated as of March 6, 1998
among ECCA Merger Corp., Eye Care Centers of America,
Inc. and the sellers Listed therein. (a)
2.4 Amendment No. 1 to the Recapitalization Agreement
dated as of April 23, 1998 among ECCA Merger Corp.,
Eye Care Centers of America, Inc, and the sellers
listed therein. (a)
2.5 Amendment No. 2 to the Recapitalization Agreement
dated as of April 24, 1998 among ECCA Merger Corp.,
Eye Care Centers of America, Inc. and the sellers
listed therein. (a)
38
41
2.6 Articles of Merger of ECCA Merger Corp. with and into
Eye Care Centers of America, Inc. dated April 24,
1998. (a)
2.7 Master Asset Purchase Agreement, dated as of August
22, 1998, by and among Eye Care Centers of America,
Inc., Mark E. Lynn, Dr. Mark Lynn & Associates, PLLC;
Dr. Bizer's Vision World, PLLC and its affiliates. (a)
2.8 Letter Agreement, dated October 1, 1998, amending and
modifying that certain Master Asset Purchase
Agreement, dated as of August 22, 1998, by and among
Eye Care Centers of America, Inc.; Mark E. Lynn; Dr.
Mark Lynn & Associates, PLLC; Dr. Bizer's VisionWorld,
PLLC and its affiliates. (a)
3.1 Restated Articles of Incorporation of Eye Care Centers
of America Inc. (a)
3.2 Statement of Resolution of the Board of Directors of
Eye Care Centers of America, Inc. designating a series
of Preferred Stock. (a)
3.3 Amended and Restated By-laws of Eye Care Centers of
America, Inc. (a)
4.1 Indenture dated as of April 24, 1998 among Eye Care
Centers of America, Inc., the Guarantors named therein
and United States Trust Company of New York, as
Trustee for the 9 1/8% Senior Subordinated Notes Due
2008 and Floating Interest Rate Subordinated Term
Securities. (a)
4.2 Form of Fixed Rate Exchange Note (included in Exhibit
4.1 Hereto). (a)
4.3 Form of Floating Rate Exchange Note (included in
Exhibit 4.1 Hereto). (a)
4.4 Form of Guarantee (included in Exhibit 4.1 hereto).
(a)
4.5 Registration Rights Agreement dated April 24, 1998
between Eye Care Centers of America, Inc., the
subsidiaries of the Company named as guarantors
therein, BT Alex. Brown Incorporated and Merrill
Lynch, Pierce, Fenner & Smith Incorporated. (a)
10.1 Form of Stockholders' Agreement dated as of April 24,
1998 by and among Eye Care of America, Inc. and the
shareholders listed therein. (a)
10.2 1998 Stock Option Plan. (a)
10.3 Amended and Restated Deferred Stock Plan of Eye Care
Centers of America, Inc. (a)
10.4 Employment Agreement dated April 24, 1998 by and
between Eye Care Centers of America, Inc. and Bernard
W. Andrews. (a)
10.5 Stock Option Agreement dated April 24, 1998 by and
between Bernard W. Andrews and Eye Care Centers of
America, Inc. (a)
10.6 Form of Employment Agreement dated January 1, 1998
between Eye Care Centers of America, Inc. and Mark T.
Pearson, William A. Shertzer, Jr., George Gebhardt and
Kent M. Keish. (a)
10.7 Employment Agreement dated March 24, 1997 between Eye
Care Centers of America, Inc. and Michele Benoit. (a)
39
42
10.8 Management Agreement, dated as of April 24, 1998, by
and between Thomas H. Lee Company and Eye Care Centers
of America, Inc. (a)
10.9 Retail Business Management Agreement, dated September
30, 1997, by and between Dr. Samit's Hour Eyes
Optometrist, P.C., a Virginia professional
corporation, and Visionary Retail Management, Inc., a
Delaware corporation. + (a)
10.10 Professional Business Management Agreement dated
September 30, 1997, by and between Dr. Samit's Hour
Eyes Optometrists, P.C., a Virginia professional
corporation, and Visionary MSO, Inc., a Delaware
corporation. + (a)
10.11 Contract for Purchase and Sale dated May 29, 1997 by
and between Eye Care Centers of America, Inc. and JDB
Real Properties, Inc. (a)
10.11 Contract for Purchase and Sale dated May 29, 1997 by
and between Eye Care Centers of America, Inc. and JDB
Real Properties, Inc. (a)
10.12 Amendment to Contract for Purchase and Sale dated July
3, 1997 by and between Eye Care Centers of America,
Inc. and JDB Real Properties, Inc. (a)
10.13 Second Amendment to Contract for Purchase and Sale
dated July 10, 1997 by and between Eye Care Centers of
America, Inc. and JDB Real Properties, Inc. (a)
10.14 Third Amendment to Contract for Purchase and Sale by
and between Eye Care Centers of America, Inc., John D.
Byram, Dallas Mini #262. Ltd. and Dallas Mini #343,
Ltd. (a)
10.15 Commercial Lease Agreement dated August 19, 1997 by
and between John D. Byram, Dallas Mini #262, Ltd. and
Dallas Mini #343, Ltd. And Eye Care Centers of
America, Inc. (a)
10.16 1997 Incentive Plan for Key Management. (a)
10.17 1998 Incentive Plan for Key Management. (a)
10.18 Employment Agreement and Noncompetition Agreement,
dated December 31, 1996 by and between Eye Care
Centers of America, Inc. and Gary D. Hahs, together
with letter, dated November 21, 1997, regarding
extension of term. (a)
10.19 Master Lease Agreement, dated August 12, 1997, by and
between Pacific Financial Company and Eye Care Centers
of America, Inc., together with all amendments, riders
and schedules thereto. (a)
10.20 Credit Agreement, dated as of April 23, 1998, among
Eye Care Centers of America, Inc., Various Lenders,
Bankers Trust Company, as Administrative Agent, and
Merrill Lynch Capital Corporation, as Syndication
Agent. (a)
10.21 Purchase Agreement, dated as of April 24, 1998, by and
among Eye Care Centers of America, Inc., the
subsidiaries of Eye Care Centers of America, Inc.
named therein, BT Alex. Brown Incorporated and Merrill
Lynch, Pierce, Fenner & Smith Incorporated. (a)
10.22 Secured Promissory Note, dated April 24, 1998, issued
by Bernard W. Andrews in favor of Eye Care Centers of
America, Inc. (a)
40
43
10.23 Form of Eye Care Centers of America, Inc. standard
managed care contract. (a)
10.24 Employment Agreement, dated July 8, 1998, by and
between Eye Care Centers of America, Inc. and David E.
McComas. (a)
10.25 Employment Agreement, dated November 2, 1998, by and
between Eye Care Centers of America, Inc. and Alan E.
Wiley. (a)
10.26 Retail Business Management Agreement, dated October 1,
1998, by and between Visionary Retail Management,
Inc., a Delaware corporation, and Dr. Mark Lynn &
Associates, PLLC, a Kentucky professional limited
liability company. + (b)
10.27 Professional Business Management Agreement, dated
October 1, 1998, by and between Visionary MSO, Inc., a
Delaware Corporation, and Dr. Mark Lynn & Associates,
PLLC, a Kentucky professional limited liability
company. + (b)
12.1 Statement re Computation of Ratios (b)
21.1 List of subsidiaries of Eye Care Centers of America,
Inc. (b)
24.1 Powers of Attorney (contained on the signature pages
to this report). (b)
27.1 Financial Data Schedule. (b)
- ----------
+ Portions of this Exhibit have been omitted pursuant to an
application for an order declaring confidential treatment filed
with the Securities and Exchange Commission.
(a) Incorporated by reference from the Registration Statement on Form
S-4 (File No. 333 - 56551).
(b) Filed herewith.
(b) The Company filed no current reports on Form 8-K with the Securities and
Exchange Commission during the thirteen weeks ended January 2, 1999.
Supplemental information to be furnished with reports filed pursuant to
Section 15(d) of the Act by Registrants which have not registered
securities pursuant to Section 12 of the Act.
No annual report or proxy materials has been sent to security holders of
the Company.
41
44
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON
ITS BEHALF BY THE UNDERSIGNED, THEREUNTO DULY AUTHORIZED, IN THE CITY OF SAN
ANTONIO, STATE OF TEXAS, ON APRIL 2, 1999.
EYE CARE CENTERS OF AMERICA, INC.
By: /s/ BERNARD W. ANDREWS
------------------------------------------
BERNARD W. ANDREWS
CHAIRMAN OF THE BOARD AND
CHIEF EXECUTIVE OFFICER
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS that each person whose signature appears below
constitutes and appoints Bernard W. Andrews and Alan E. Wiley and each of them,
with the power to Act without the other, his true and lawful attorney-in-fact
and agent, with full power of substitution and resubstitution, for him or in his
name, place and stead, in any and all capacities to sign any and all amendments
to this report, and to file the same, with all exhibits thereto, and other
documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power
and authority to do and perform each and every Act and thing requisite or
necessary to be done in and about the premises, as fully to all intents and
purposes as he might or could do in person, hereby ratifying and confirming all
that said attorneys-in-fact and agents or any of them, or their or his
substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1934, this report has
been signed by the following persons in the capacities and on the dates
indicated.
SIGNATURE TITLE DATE
--------- ----- ----
Chairman of the Board and Chief April 2, 1999
/s/ Bernard W. Andrews Executive Officer
- -------------------------------------------------- (Principal Executive Officer)
BERNARD W. ANDREWS
Executive Vice President and Chief April 2, 1999
/s/ Alan E. Wiley Financial Officer
- -------------------------------------------------- (Principal Financial and
ALAN E. WILEY Accounting Officer)
/s/ Norman S. Matthews Director April 2, 1999
- --------------------------------------------------
NORMAN S. MATTHEWS
/s/ Antoine G. Treuille Director April 2, 1999
- --------------------------------------------------
ANTOINE G. TREUILLE
/s/ Anthony J. DiNovi Director April 2, 1999
- --------------------------------------------------
ANTHONY J. DINOVI
/s/ Warren C. Smith, Jr. Director April 2, 1999
- --------------------------------------------------
WARREN C. SMITH, JR.
/s/ Charles A. Brizius Director April 2, 1999
- --------------------------------------------------
CHARLES A. BRIZIUS
42
45
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
EYE CARE CENTERS OF AMERICA, INC. AND SUBSIDIARIES
Report of Independent Auditors F-2
Consolidated Balance Sheets at January 3, 1998 and January 2, 1999. F-3
Consolidated Statements of Operations for the Years Ended December 28, 1996,
January 3, 1998 and January 2, 1999. F-4
Consolidated Statements of Shareholders' Equity/(Deficit) as of December 28, 1996,
January 3, 1998 and January 2, 1999. F-5
Consolidated Statements of Cash Flows for the Years Ended December 28, 1996,
January 3, 1998 and January 2, 1999. F-6
Notes to the Consolidated Financial Statements F-8
Schedule II - Consolidated Valuation and Qualifying Accounts - for the Years
Ended December 28, 1996, January 3, 1998 and January 2, 1999. F-37
46
REPORT OF INDEPENDENT AUDITORS
Board of Directors and Shareholders
Eye Care Centers of America, Inc.
San Antonio, Texas
We have audited the accompanying consolidated balance sheets of Eye Care Centers
of America, Inc. and Subsidiaries as of January 2, 1999 and January 3, 1998, and
the related consolidated statements of operations, shareholders' equity
(deficit), and cash flows for the fiscal years ended January 2, 1999, January 3,
1998, and December 28, 1996. Our audits also included the financial statement
schedules listed in the Index at Item 14(a). These financial statements and
schedules are the responsibility of the Company's management. Our responsibility
is to express an opinion on these financial statements and schedules based on
our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the consolidated financial position of Eye
Care Centers of America, Inc. and Subsidiaries at January 2, 1999 and January
3, 1998, and the consolidated results of their operations and their cash flows
for the fiscal years ended January 2, 1999, January 3, 1998, and December 28,
1996, in conformity with generally accepted accounting principles. Also, in our
opinion, the related financial statement schedules, when considered in relation
to the basic financial statements taken as a whole, present fairly in all
material respects the information set forth therein.
/s/ ERNST & YOUNG LLP
San Antonio, Texas
March 10, 1999
F-2
47
EYE CARE CENTERS OF AMERICA, INC.
CONSOLIDATED BALANCE SHEETS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
---------- ----------
ASSETS January 3, January 2,
1998 1999
---------- ----------
Current assets:
Cash and cash equivalents $ 7,172 $ 5,127
Accounts and notes receivable, less allowance for doubtful accounts of $318 in 1997
and $559 in 1998 5,722 6,453
Inventory, less reserves of $561 in 1997 and $852 in 1998 26,007 26,977
Prepaid expenses and other 3,566 2,286
Deferred income taxes 386 391
--------- ---------
Total current assets 42,853 41,234
Property and equipment, net of accumulated depreciation and amortization of
$41,766 in 1997 and $58,134 in 1998 57,212 68,118
Intangibles, net of accumulated amortization of $6,578 in 1997 and $10,344 in 1998 75,279 102,459
Other assets 4,800 11,096
--------- ---------
$ 180,144 $ 222,907
========= =========
LIABILITIES AND SHAREHOLDERS' EQUITY/(DEFICIT)
Current liabilities:
Accounts payable $ 12,801 $ 20,921
Current portion of long-term debt 7,003 3,578
Deferred revenue 3,804 5,331
Accrued payroll expense 2,969 2,788
Accrued interest 2,976 3,347
Other accrued expenses 9,200 8,186
--------- ---------
Total current liabilities 38,753 44,151
Deferred income taxes 384 391
Long-term debt, less current maturities 115,386 242,945
Deferred rent 3,042 3,246
Deferred gain 2,334 2,175
--------- ---------
Total liabilities 159,899 292,908
--------- ---------
Mandatorily redeemable cumulative preferred stock 12,117 --
Commitments and contingencies
Shareholders' equity/(deficit):
Common stock, par value $.01 per share; 20,000,000 shares authorized; issued
and outstanding 1,011,548 in 1997 and 7,451,030 in 1998 10 75
Preferred stock, par value $.01 per share, 300,000 share authorized, issued
and outstanding in 1998 -- 32,793
Additional paid-in capital 31,245 60,958
Accumulated deficit (23,127) (163,827)
--------- ---------
Total shareholders' equity/(deficit) 8,128 (70,001)
--------- ---------
$ 180,144 $ 222,907
========= =========
The accompanying notes are an integral part of
these consolidated financial statements
F-3
48
EYE CARE CENTERS OF AMERICA, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Fiscal Year Ended
------------------------------------------------
December 28, January 3, January 2,
1996 1998 1999
------------ ---------- ----------
Optical sales $ 158,224 $ 218,958 $ 235,236
Management fees -- 653 2,615
--------- --------- ---------
Net revenues 158,224 219,611 237,851
Operating costs and expenses:
Cost of goods sold 51,884 77,134 80,636
Selling, general and administrative expenses 91,897 120,319 132,390
Recapitalization and other expenses -- -- 25,803
Amortization of intangibles:
Goodwill 1,424 2,722 3,552
Noncompete and other intangibles 1,514 148 153
--------- --------- ---------
Total operating costs and expenses 146,719 200,323 242,534
--------- --------- ---------
Income (loss) from operations 11,505 19,288 (4,683)
Interest expense, net 9,899 13,738 19,159
In-substance defeased bonds
interest expense, net -- -- 2,418
--------- --------- ---------
Income (loss) before income taxes 1,606 5,550 (26,260)
Income tax expense 188 335 13
--------- --------- ---------
Net income (loss) before extraordinary item 1,418 5,215 (26,273)
Extraordinary loss on early extinguishment of
long-term debt -- -- 8,355
--------- --------- ---------
Net income (loss) $ 1,418 $ 5,215 $ (34,628)
========= ========= =========
The accompanying notes are an integral part of
these consolidated financial statements.
F-4
49
EYE CARE CENTERS OF AMERICA, INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY/(DEFICIT)
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Additional Cumulative Accumulated Total
Common Stock Paid-In Translation Preferred (Deficit) Shareholders'
Shares Amount Capital Adjustment Stock Earnings Equity/(deficit)
---------- ---------- ---------- ----------- --------- ----------- ----------------
Balance at December 30, 1995 996,774 $ 10 $ 31,760 $ (679) $ -- $ (29,760) $ 1,331
Proceeds from deferred stock
compensation plan -- -- 158 -- -- -- 158
Purchase of deferred stock -- -- (182) -- -- -- (182)
shares
Purchase of common stock (6,452) -- (200) -- -- -- (200)
Issuance of common stock 10,000 -- 310 -- -- -- 310
Stock options exercised 8,226 -- 238 -- -- -- 238
Dividends accrued on
mandatorily redeemable -- -- (220) -- -- -- (220)
preferred stock
Translation and other -- -- -- 679 -- -- 679
Net income -- -- -- -- -- 1,418 1,418
---------- ---------- ---------- ---------- ---------- ---------- ----------
Balance at December 28, 1996 1,008,548 $ 10 $ 31,864 $ -- $ -- $ (28,342) $ 3,532
Proceeds from deferred stock
compensation plan -- -- 179 -- -- -- 179
Purchase of deferred stock -- -- (96) -- -- -- (96)
shares
Stock options exercised 3,000 -- 195 -- -- -- 195
Dividends accrued on
mandatorily redeemable -- -- (897) -- -- -- (897)
preferred stock
Net income -- -- -- -- -- 5,215 5,215
---------- ---------- ---------- ---------- ---------- ---------- ----------
Balance at January 3, 1998 1,011,548 $ 10 $ 31,245 $ -- $ -- $ (23,127) $ 8,128
Dividends accrued on
mandatory redeemable
preferred stock -- -- (268) -- -- -- (268)
Repurchase of common stock and
conversion of options and
warrants as a part of the
recapitalization (1,011,548) (10) (30,977) -- -- (98,198) (129,185)
Common stock issued as a part
of the recapitalization 565,923 6 70,684 -- -- -- 70,690
Rollover of shares of common stock
to common stock and preferred
stock as a part of the
recapitalization 45,030 -- 5,624 -- 2,250 (7,874) --
Common stock issued for shareholder
loan as a part of the
recapitalization 8,005 -- -- -- -- -- --
Preferred stock issuance as a part
of the recapitalization -- -- -- -- 27,750 -- 27,750
Recapitalization fees -- -- (12,733) -- -- -- (12,733)
Stock split 6,808,538 68 (68) -- -- -- --
Dividends accrued on preferred
stock -- -- (2,793) -- 2,793 -- --
Stock buyback (19,680) -- (205) -- -- -- (205)
Issuance of common stock 43,227 1 449 -- -- -- 450
Net loss -- -- -- -- -- (34,628) (34,628)
---------- ---------- ---------- ---------- ---------- ---------- ----------
Balance at January 2, 1999 7,451,043 $ 75 $ 60,958 $ -- $ 32,793 $ (163,827) $ (70,001)
========== ========== ========== ========== ========== ========== ==========
The accompanying notes are an integral part of
these consolidated financial statements
F-5
50
EYE CARE CENTERS OF AMERICA, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Fiscal Year Ended
------------------------------------------
December 28, January 3, January 2,
1996 1998 1999
------------ ---------- ----------
Cash flows from operating activities:
Net income (loss) $ 1,418 $ 5,215 $ (34,628)
Adjustments to reconcile net income (loss) to net cash provided by
operating activities:
Depreciation 9,646 12,131 12,345
Amortization of intangibles 2,938 2,870 3,705
Other amortization 671 983 1,578
Amortization of deferred gain -- (53) (159)
Deferred revenue (378) 232 654
Deferred rent 417 602 204
Other 217 (125) (515)
(Gain) loss on disposition of property and equipment 80 (120) 633
Extraordinary loss on early extinguishment of long-term debt -- -- 8,355
Changes in operating assets and liabilities:
Accounts and notes receivable (23) (1,667) (189)
Inventory 325 951 68
Prepaid expenses and other 194 (2,848) 1,168
Accounts payable and accrued liabilities (1,542) (2,655) 6,974
-------- -------- ---------
Net cash provided by operating activities 13,963 15,516 193
-------- -------- ---------
Cash flows from investing activities:
Acquisition of property and equipment (4,233) (9,470) (20,656)
Net outflow for Visionworks Holdings, Inc. common stock (53,521) -- --
Proceeds from sale of property and equipment -- 5,731 1,196
Payment received on notes receivable 17 375 177
Net outflow for The Samit Group, Inc. -- (17,462) --
Net outflow for the VisionWorld acquisition -- -- (33,042)
Purchase of investment securities-restricted -- -- (76,618)
Maturity of investment securities-restricted -- -- 78,400
-------- -------- ---------
Net cash used in investing activities $(57,737) $(20,826) $ (50,543)
-------- -------- ---------
F-6
51
EYE CARE CENTERS OF AMERICA, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Fiscal Year Ended
--------------------------------------------
December 28, January 3, January 2,
1996 1998 1999
------------ ----------- ------------
Cash flows from financing activities:
Payments related to deferred compensation $ (382) $ (96) $ --
Proceeds from issuance of long-term debt 40,000 9,000 234,611
Proceeds from the stock option exercises 238 195 --
Proceeds from the issuance of common stock 310 -- 71,140
Proceeds from issuance of preferred stock 11,000 -- 27,750
Payments related to debt issuance (1,350) -- (11,153)
Payments to retire mandatorily redeemable preferred stock -- -- (12,385)
Redemption of common stock -- -- (129,390)
Recapitalization fees -- -- (12,733)
Payments on debt and capital leases (500) (7,440) (112,917)
Proceeds from deferred stock compensation plan 158 179 --
Payment of call premium -- -- (4,200)
Payment of in-substance defeased bonds interest expense, net -- -- (2,418)
--------- --------- ---------
Net cash (used in) provided by financing activities 49,474 1,838 48,305
--------- --------- ---------
Effect of exchange rate changes on cash and cash
equivalents 577 -- --
--------- --------- ---------
Net increase (decrease) in cash and cash equivalents 6,277 (3,472) (2,045)
Cash and cash equivalents at beginning of period 4,367 10,644 7,172
--------- --------- ---------
Cash and cash equivalents at end of period $ 10,644 $ 7,172 $ 5,127
========= ========= =========
Supplemental cash flow disclosures:
Cash paid during the period for:
Interest $ 8,885 $ 13,580 $ 17,781
Taxes $ 163 $ 160 $ --
Noncash investing and financing activities:
Additions of property and equipment $ 214 $ 495 $ 588
Dividends accrued on mandatorily redeemable
cumulative preferred stock $ 220 $ 897 $ 268
Dividends accrued on preferred stock $ -- $ -- $ 2,793
Adjustment of Visionworks property and equipment
to fair market value $ -- $ 4,684 $ --
Adjustment of Hour Eyes property and equipment
to fair market value $ -- $ -- $ 43
Rollover of common stock to
common stock as part of
the recapitalization $ -- $ -- $ 5,624
Rollover of common stock to
preferred stock as a part of
the recapitalization $ -- $ -- $ 2,250
Loan to shareholder to acquire
common stock $ -- $ -- $ 1,000
Adjustment of noncompete
agreement to goodwill $ -- $ -- $ 735
The accompanying notes are an integral part of
these consolidated financial statements
F-7
52
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
1. DESCRIPTION OF BUSINESS AND ORGANIZATION
Description of Business. Eye Care Centers of America, Inc. (the "Company")
operates super optical retail stores which sell prescription eyewear, sunglasses
and ancillary optical products, and feature on-site laboratories. The Company's
operations are located in the Southwest, Midwest, Southeast, along the Gulf
Coast, in the Mid-Atlantic states and in the Pacific Northwest.
Organization. On March 6, 1998, ECCA Merger Corp. ("Merger Corp."), a
Delaware corporation formed by Thomas H. Lee Company ("THL Co."), and the
Company entered into a recapitalization agreement (the "Recapitalization
Agreement") providing for, among other things, the merger of such corporation
with and into the Company (the "Merger" and, together with the financing of the
recapitalization and related transactions described below, the
"Recapitalization"). Upon consummation of the Recapitalization on April 24,
1998, Thomas H. Lee Equity Fund IV, L.P. ("THL Fund IV") and other affiliates of
THL Co. (collectively with THL Fund IV and THL Co., "THL") owned approximately
89.7% of the issued and outstanding shares of common stock of the Company
("Common Stock"), existing shareholders (including management) of the Company
retained approximately 7.3% of the issued and outstanding Common Stock and
management purchased additional shares representing approximately 3.0% of the
issued and outstanding Common Stock.
The Company financed the Recapitalization with (a) the proceeds from the
offering of $150.0 million aggregate principal amount of its senior subordinated
notes due 2008, consisting of $100.0 million aggregate principal amount of its 9
1/8% Senior Subordinated Notes due 2008 (the "Fixed Rate Notes") and $50.0
million aggregate principal amount of its Floating Interest Rate Subordinated
Term Securities due 2008 (the "Floating Rate Notes" and, together with the Fixed
Rate Notes, the "Initial Notes") (b) approximately $55.0 million of borrowings
under the New Credit Facility (defined herein) and (c) approximately $99.4
million from the sale of capital stock to THL, Bernard W. Andrews and other
members of management (the "Equity Contribution") consisting of (i)
approximately $71.7 million from the sale of Common Stock and (ii) approximately
$27.7 million from the sale of shares of a newly created series of preferred
stock of the Company ("New Preferred Stock"). Additionally, existing
stockholders rolled over $7.9 million in Common Stock and New Preferred Stock.
The proceeds from such bank borrowings, the sale of the Notes, and the Equity
Contribution was used principally to finance the conversion into cash of the
shares of Common Stock which were not retained by existing stockholders, to
refinance certain existing indebtedness of the Company, to redeem certain
outstanding preferred stock of the Company and to pay related fees and expenses
of the Recapitalization.
In connection with the Recapitalization, the Company in-substance defeased
its previously issued 12% Senior Notes due 2003 (the "Senior Notes") by
depositing with the trustee for the senior notes (i) an irrevocable notice of
redemption of the Senior Notes on October 1,
F-8
53
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
1998 and (ii) United States government securities in an amount necessary to
yield on October 1, 1998 $78.4 million, which constitutes the principal amount,
premium and interest payable on the Senior Notes on the October 1, 1998
redemption date. The Bonds were defeased on October 1, 1998 and the company
recorded an extraordinary charge of $4.2 million on the statement of operations
for defeasance costs during the third quarter related to the call premium on the
bonds. Additionally, an extraordinary loss of $4.2 million related to the
write-off of unamortized deferred loan costs related to the early extinguishment
of debt was recorded as part of the Recapitalization.
As a result of the Recapitalization, the Company has incurred approximately
$25.1 million of non-recurring expenses. These expenses consisted of
compensation expense recorded in connection with the exercise of employee stock
options and other transaction related expenses. Additionally, the Company
incurred approximately $0.7 million in connection with a point-of-sale system
write-off.
Effective April 24, 1998, the Board of Directors of the Company authorized
a twelve-for-one stock split to shareholders of record on that date. The par
value of the Common Stock remained at $0.01. The stock split had no effect on
the percentage ownership of shareholders.
Recent Acquisitions. On September 27, 1996 ("Visionworks Acquisition") the
Company acquired all of the outstanding shares of the capital stock of
Visionworks Holdings, Inc. ("VHI"). At the time of the acquisition, VHI was a 60
store optical retailer located along the Atlantic Coast from Florida to
Washington, D.C. with 49 superstores and 11 optical centers located near Eckerd
Corporation drug stores. The Visionworks Acquisition price of $61.5 million was
financed through (i) the issuance of $11.0 million in mandatorily redeemable
preferred stock plus nondetachable warrants to purchase 150,000 shares of common
stock of the Company, (ii) borrowing under an amended and restated credit
facility agreement of $40.0 million, (iii) existing cash from the Company and
(iv) the assumption of a capital lease with Eckerd Corporation.
The Visionworks Acquisition was accounted for using the purchase method of
accounting. Accordingly, a portion of the purchase price was allocated to the
identifiable net assets acquired based on their estimated fair values with the
balance of the purchase price, $38.6 million, included in goodwill. The cost in
excess of net assets of the business acquired is being amortized over 25 years.
Results of operations for this acquired entity were included in the Company's
operating results from the date of acquisition.
Effective September 30, 1997, the Company acquired The Samit Group, Inc.
and its subsidiaries (collectively, "TSGI"), with ten stores in Maryland and
Washington, D.C., and certain of the assets of Hour Eyes Doctors of Optometry,
P.C., a Virginia professional corporation formerly known as Dr. Samit's Hour
Eyes Optometrist, P.C. (the "PC"), and simultaneously entered into a long-term
management agreement with the PC to manage the PC's twelve stores in Virginia
(collectively, the "Hour Eyes Acquisition"). The acquisition cost to the Company
was $22.25 million less TSGI's acquisition date liabilities. The Hour Eyes
Acquisition was
F-9
54
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
financed through (i) borrowing under the Amended Credit Facility (defined
herein) of $9.0 million and (ii) existing cash from the Company.
The Hour Eyes Acquisition, which occurred during the fourth quarter of
1997, was accounted for using the purchase method of accounting. Accordingly, a
portion of the purchase price was allocated to the identifiable net assets
acquired based on their estimated fair values with the balance of the purchase
price included in goodwill. Included in identifiable net assets acquired is a
management agreement being amortized over 25 years and a noncompete agreement
being amortized over three years. The cost in excess of identifiable net assets
of the business acquired is being amortized over 25 years.
Results of operations for this acquired entity were included in the
Company's operating results from the date of acquisition. As a result of the
long-term business management agreement with the PC, the Company records a
management fee but does not include the results of operations from the twelve
Virginia stores in the Company's consolidated results of operations.
On September 30, 1998, the Company acquired (the "VisionWorld Acquisition")
substantially all of the assets, properties and rights (collectively, the
"Assets") of Dr. Bizer's VisionWorld, PLLC and its affiliates: Doctor's
ValuVision, PLLC; Bizer Enterprises, LLC; Bizer Service Company, LLC; Eye Care
Associates, PLLC; Optical Processors, LLC; The Eye Surgery Center, PSC; American
Vision Administrators, LLC; and Vision for Less of Kentucky, Inc. (collectively,
the "Companies"). Each of the Companies is engaged in the business of providing
optometric and ophthalmologic services, selling optical goods and providing
other related services in Kentucky, Tennessee, Indiana and Missouri. Results of
operations for this acquisition were included in the Company's operating results
from the date of acquisition. Simultaneously with the VisionWorld Acquisition,
the Company entered into a long-term business management agreement with a
private optometrist to manage the stores. The aggregate cash consideration paid
by the Company in the VisionWorld Acquisition was $32.3 million. The VisionWorld
Acquisition was financed through borrowings under the Company's Acquisition
Facility (defined herein) and $3.0 million of the Company's existing cash.
The VisionWorld Acquisition was accounted for using the purchase method of
accounting. Accordingly, a portion of the purchase price has been preliminarily
allocated to the identifiable net assets acquired based on their estimated fair
values with the balance of the purchase price included in goodwill. Included in
identifiable net assets acquired is a noncompete agreement being amortized over
five years. The cost in excess of identifiable net assets acquired is being
amortized over 25 years on a straight-line basis. Assuming the VisionWorld
Acquisition had occurred at the beginning of fiscal year 1998 the consolidated
pro forma results of operations (unaudited) would have shown the following
results:
F-10
55
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
FISCAL FISCAL
1997 1998
---------- ---------
Revenues $ 254,184 $ 266,122
Net income/(loss) before
extraordinary item $ 4,477 $ (27,555)
Net income/(loss) $ 4,477 $ (35,910)
Such pro forma amounts are not necessarily indicative of what actual
consolidated results of operations might have been if the acquisition had been
effective at the beginning of such fiscal years nor should such results be
deemed predictive of future results of operations.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation. The financial statements include the accounts of the
Company and its wholly owned subsidiaries, Enclave Advancement Group, Inc., ECCA
Managed Vision Care, Inc., VisionWorks Holdings, Inc. and Eye Care Holdings,
Inc. All significant intercompany accounts and transactions have been eliminated
in consolidation. Certain reclassifications have been made to the prior period
statements to conform to the current period presentation.
Use of Estimates. In preparing financial statements in conformity with
generally accepted accounting principles, management is required to make
estimates and assumptions. These estimates and assumptions affect the reported
amount of assets and liabilities, the disclosure of contingent assets and
liabilities at the date of the financial statements and revenues and expenses
during the reporting period. Actual results could differ from these estimates.
Reporting Periods. The Company uses a 52/53-week reporting format. The
fiscal years ended 1996 and 1998 consisted of 52 weeks. The fiscal year ended
1997 consisted of 53 weeks.
Segment Disclosure. As of January 4, 1998, the Company adopted SFAS No. 131,
Disclosures about Segments of an Enterprise and Related Information ("Statement
131"). Statement 131 establishes standards for the way that public business
enterprises report information about operating segments in annual financial
statements and requires that those enterprises report selected information about
operating segments in interim financial reports. Statement 131 also establishes
standards for related disclosures about products and services, geographic areas,
and major customers. The adoption of Statement 131 did not affect results of
operations or financial position. Furthermore, the statement did not affect
disclosure of segment information as the Company operates in one business
segment, the optical retail segment.
The first set of criteria for determining what constitutes a segment is
dependent upon a segment being a profit and expense center, the availability of
discrete financial information, and the level of review utilized by the
Company's chief operating decision maker to assess performance and allocate
resources. While the Company's stores are broken into various operating units
for review purposes, resources are not allocated based upon these units.
Furthermore, these operating units fall under Statement 131's aggregation
criteria, which allow
F-11
56
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
combination of units for reporting purposes. The aggregation of operating units
must be consistent with the objectives and principles of Statement 131, the
operating segments have similar economic characteristics, and the units have
similar basic characteristics in relation to the nature of the
products/services, production processes, type/class of customer and method of
distribution. Management believes each of these criteria is met and that
disclosing the company's results as one segment is appropriate.
Foreign Currency Translation. Prior to December 1996, the financial
position and results of operations of the Company's subsidiary in Mexico were
measured using the local currency as the functional currency. Assets and
liabilities denominated in foreign currencies were translated into U.S. dollars
at exchange rates in effect at year-end, while revenues and expenses were
translated at average exchange rates prevailing during the year. Through the
third quarter of 1996, the resulting translation gains and losses were charged
directly to cumulative translation adjustment, a component of stockholders'
equity. During the fourth quarter of 1996, the Mexican economy was assessed by
management to be highly inflationary based on the decline of the peso to the
U.S. dollar and therefore, impacted the Company's investment in its subsidiary
in Mexico. As such the cumulative translation adjustment as of December 28, 1996
of $560 was recorded through the results of operations. During fiscal year 1997
and 1998, the U.S. dollar represented the functional currency of the Mexico
subsidiary. During fiscal year 1997 and 1998, translation gains and losses are
included in determining net income and foreign currency transaction gains and
losses are included in net income. The retail Mexico location was sold in the
fourth quarter of fiscal 1998 and all operations of the subsidiary have ceased.
Cash and Cash Equivalents. All short-term investments that mature in less
than 90 days when purchased are considered cash equivalents for purposes of
disclosure in the consolidated balance sheets and consolidated statements of
cash flows. Cash equivalents are stated at cost, which approximates market
value.
Accounts and Notes Receivable. Accounts and notes receivable include
receivables from credit card companies, insurance reimbursements, merchandise,
rent, license fee receivables and notes receivable from certain optometrists
which have purchased optical equipment from the Company. Merchandise receivables
result from product returned to vendors pending credit or exchange for new
product.
Inventory. Inventory consists principally of eyeglass frames, ophthalmic
lenses and contact lenses and is stated at the lower of cost or market. Cost is
determined using the weighted average method which approximates the first-in,
first-out (FIFO) method.
The Company purchases approximately 61% of its lenses from two principal
vendors and while these suppliers provide a significant share of the lenses used
by the Company, lenses are considered a commodity product and can be purchased
from a number of other vendors on comparable terms. The Company believes its
relationships with its existing vendors are satisfactory.
F-12
57
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Prepaid Expenses - Store Preopening Costs. Preopening costs directly
associated with store openings are capitalized and amortized using the
straight-line method over one year following each store's opening. Amortization
expense of store preopening costs for fiscal 1996, 1997 and 1998 was
approximately $126, $178, and $234 respectively. Store preopening costs of $156
and $405 are included in Prepaid Expenses and Other as of January 3, 1998, and
January 2, 1999, respectively.
In April 1998, the AICPA issued Statement of Position 98-5, Reporting on
the Costs of Start-Up Activities ("SOP 98-5"). SOP 98-5 requires that start-up
costs, including organizational costs, be expensed as incurred. The SOP broadly
defines start-up activities as those one-time activities related to opening a
new facility, introducing a new product or services, conducting business in a
new territory, conducting business with a new class of customer or beneficiary,
initiating a new process in an existing facility, or commencing some new
operation. The SOP is effective for most entities for fiscal years beginning
after December 15, 1998. As such, the Company adopted this SOP for the fiscal
year ended January 1, 2000. The effect of the adoption of the SOP on the
Company's results of operations was a write off of previously capitalized
pre-opening and organization costs of approximately $500, which will be
reflected as a cumulative effect of change in accounting principle during the
first quarter of fiscal 1999. Additionally, the Company expects annual charges
to earnings of approximately $200 related to store opening costs.
Income Taxes. The Company records income taxes under FASB No. 109 using the
liability method. Under this method, deferred tax assets and liabilities are
determined based on differences between financial reporting and tax bases of
assets and liabilities and are measured using the enacted tax rates and laws
that will be in effect when the differences are expected to reverse.
Property and Equipment. Property and equipment is recorded at cost. For
property and equipment acquired through acquisitions, balances are adjusted to
reflect their fair market value, as determined by an independent appraisal. For
financial statement purposes, depreciation of building, furniture and equipment
is calculated using the straight-line method over the estimated useful lives of
the assets. Leasehold improvements are amortized on a straight-line method over
the shorter of the life of the lease or the estimated useful lives of the
assets. Depreciation of capital leased assets is included in depreciation
expense and is calculated using the straight-line method over the term of the
lease.
Estimated useful lives are as follows:
Building 20 years
Furniture and equipment 3 to 10 years
Leasehold improvements 5 to 10 years
Maintenance and repair costs are charged to expense as incurred.
Expenditures for significant betterments are capitalized.
F-13
58
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Intangibles. Intangibles principally consist of the amounts of excess
purchase price over the market value of acquired net assets ("goodwill"),
management agreements, and noncompete agreements. Goodwill is being amortized on
a straight-line basis over a period of 25 years. The noncompete agreement
intangibles, which are related to the Hour Eyes Acquisition and the VisionWorld
Acquisition, are being amortized over the life of the agreements on a
straight-line basis.
Other Assets. Other assets consist primarily of deferred debt financing
costs associated with the Recapitalization. These costs are being amortized into
expense over the life of the associated debt.
Long-Lived Assets. Periodically, the Company evaluates the realizability of
long-lived assets based upon expectations of nondiscounted cash flows and
operating income. Based upon its most recent analysis, the Company believes that
no impairment of long-lived assets exists at January 2, 1999.
Deferred Revenue - Replacement Certificates and Warranty Contracts. At the
time of a frame sale, some customers purchase a warranty contract covering frame
defects or damage during the 12-month period subsequent to the date of the sale.
Revenue relating to these contracts is deferred and recognized on a
straight-line basis over the life of the warranty contract (one year). Costs
incurred to fulfill the warranty are expensed when incurred. Certain frame
purchases include a one-year warranty period without requiring the separate
purchase of a warranty contract. Reserves are established for the expected cost
of repair related to these frame sales. At the end of fiscal 1997 and 1998, the
Company has established a reserve of approximately $100 and $392, respectively,
related to these warranties which is included in other accrued expenses on the
accompanying balance sheet.
Revenue Recognition. Sales and related costs are recognized by the Company
upon the sale of products at company-owned retail locations. Licensing fees
collected from independent optometrists for using the Company's trade name
"Master Eye Associates" are recognized when earned. Historically, the Company's
highest sales occur in the first and third quarters.
Advertising Costs. Advertising costs of the Company include costs related
to broadcast and print media advertising expenses. The Company expenses
production costs and media advertising costs the first time the advertising
takes place. For the fiscal years ended 1996, 1997 and 1998, advertising costs
amounted to approximately $21,779, $24,611 and $23,816, respectively.
F-14
59
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Interest Expense, Net. Interest expense, net consists of the following:
Year-Ended
----------------------------------------------------------------
December 28, 1996 January 3, January 2,
1998 1999
---------------------- ------------------ ----------------
Interest expense $ 10,342 $ 14,380 $ 23,804
Interest income (443) (642) (2,227)
---------------------- ------------------ ----------------
Interest expense, net $ 9,899 $ 13,738 $ 21,577
====================== ================== ================
Pension Benefits. In February 1998, the Financial Accounting Standards Board
(FASB) issued SFAS No. 132, Employers' Disclosures about Pensions and Other
Postretirement Benefits, which is required to be adopted in years beginning
after December 15, 1998. As the Company has no pension plans or postretirement
benefits, the adoption of this statement will not have an effect on earnings or
the financial position of the Company.
Stock Based Compensation. The Company grants stock options for a fixed
number of shares to employees with an exercise price equal to the fair value of
the shares at the date of grant. During the first quarter of 1996, the Company
adopted FASB No. 123, "Accounting for Stock-Based Compensation". In accordance
with FASB No. 123, the Company has continued to account for stock option grants
in accordance with APB Opinion No. 25, "Accounting for Stock Issues to
Employees", and, accordingly, recognized no compensation expense for the stock
option grants.
Comprehensive Income. As of January 4, 1998, the Company adopted SFAS No.
130, Reporting Comprehensive Income ("Statement 130"). Statement 130 establishes
new rules for the reporting and display of comprehensive income and its
components; however, the adoption of Statement 130 had no impact on the
Company's net income or shareholders' equity (deficit). There were no other
components of comprehensive income other than net income (loss).
Derivatives. Derivatives are used to hedge interest rate exposure by
modifying the interest rate characteristics of related balance sheet
instruments. The specific criteria for derivatives used for these purposes are
described below. Derivatives used as hedges must be effective at reducing the
risk associated with the exposure being hedged and must be designated as a hedge
at the inception of the derivative contract. Derivatives currently used for
hedging purposes include interest rate swaps. These swap transactions allow
management to structure the interest rate sensitivity of the liability side of
the Company's long-term debt. The fair value of derivative contracts are carried
off-balance sheet and the unrealized gains or losses on derivative contracts are
generally deferred. The interest component associated with derivatives used as
hedges or to modify the interest rate characteristics of liabilities is
recognized over the life of the
F-15
60
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
contract in interest expense. Upon contract settlement or early termination, the
cumulative change in the market value of such derivatives is recorded as ad
adjustment to the carrying value of the underlying liability and recognized in
interest expense over the expected remaining life of the derivative contract. In
instances where the underlying hedge instrument is repaid, the cumulative change
in the value of the associated derivative is recognized immediately in earnings.
In June 1998, the Financial Accounting Standards Board issued SFAS No. 133,
Accounting for Derivative Instruments and Hedging Activities, which is required
to be adopted in years beginning after June 15, 1999. The statement permits
early adoption as of the beginning of any fiscal quarter after its issuance. The
statement will require the Company to recognize all derivatives on the balance
sheet at fair value. Derivatives that are not hedges must be adjusted to fair
value through income. If the derivative is a hedge, depending on the nature of
the hedge, changes in the fair value of derivatives will either be offset
against the change in fair value of the hedged assets, liabilities, or firm
commitments through earnings or recognized in other comprehensive income until
the hedged item is recognized in earnings. The ineffective portion of a
derivative's change in fair value will be immediately recognized in earnings.
The Company has not yet determined what the effect of SFAS No. 133 will be on
the earnings and financial position of the Company.
3. RELATED PARTY TRANSACTIONS
Prior to the Recapitalization, the Company was party to an agreement with
Desai Capital Management, Inc. ("DCMI") whereby the Company paid DCMI $144 per
year as an advisory fee for consulting and strategic advice and $56 per year for
the consulting services of certain Board of Directors members who are also
employees and/or officers of DCMI. As a result of the Recapitalization, the
agreement with DCMI has been canceled, and DCMI is no longer a majority
shareholder of the Company.
The Company and THL Co. entered into a management agreement as of the
closing date of the Recapitalization (the "Management Agreement"), pursuant to
which THL Co. received a financial advisory fee of $6.0 million in connection
with structuring, negotiating and arranging the Recapitalization and related
debt financing. In addition, pursuant to the Management Agreement, THL Co. will
initially receive $500 per year plus expenses for management and other
consulting services provided to the Company. After a term of ten years from the
closing date, the Management Agreement is automatically renewable on an annual
basis unless either party serves notice of termination at least ninety days
prior to the renewal date.
F-16
61
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
4. PREPAID EXPENSES AND OTHER
Prepaid expenses and other consists of the following:
January 3, January 2,
1998 1999
---------------- ----------------
Prepaid insurance $102 $787
Prepaid store supplies 927 1,001
Prepaid rentals 2,282 16
Other 255 482
---------------- ----------------
$3,566 $2,286
================ ================
5. PROPERTY AND EQUIPMENT
Property and equipment, net consists of the following:
January 3, January 2,
1998 1999
-------------- --------------
Land $ 6,000 $ 6,000
Building 3,144 3,201
Furniture and equipment 57,737 77,775
Leasehold improvements 32,097 39,276
-------------- --------------
98,978 126,252
Less accumulated depreciation and amortization (41,766) (58,134)
-------------- --------------
Property and equipment, net $ 57,212 $ 68,118
============== ==============
F-17
62
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
6. INTANGIBLE ASSETS
The following is a summary of the components of intangible assets along
with the related accumulated amortization for the fiscal years then ended.
January 3, January 2,
1998 1999
-------------- --------------
Goodwill and other $ 72,869 $ 103,989
Management agreement 7,988 7,988
Less accumulated amortization (6,495) (10,148)
-------------- --------------
Net 74,362 101,829
-------------- --------------
Noncompete agreements 1,000 826
Less accumulated amortization (83) (196)
-------------- --------------
Net 917 630
-------------- --------------
Intangibles, net $ 75,279 $ 102,459
============== ==============
The Company obtained an appraisal of the noncompete agreement related to the
Hour Eyes Acquisition. Based on the appraisal, the value of the noncompete asset
was reduced by $735 with a corresponding increase to goodwill.
7. OTHER ACCRUED EXPENSES
Other accrued expenses consists of the following:
January 3, January 2,
1998 1999
-------------- --------------
Property taxes $ 1,266 $ 1,159
Professional fees 489 478
Payroll and sales/use taxes 573 622
Store expenses 1,198 952
Insurance 354 230
Construction 495 1,083
Advertising 652 1,598
Acquisition liability 2,250 --
Other 1,923 2,064
-------------- --------------
Other accrued expenses $ 9,200 $ 8,186
============== ==============
F-18
63
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
8. LONG-TERM DEBT
New Credit Facility. In September 1997, the Company entered into an amended
and restated credit agreement which provided for $49.0 million in term loans and
$5.0 million in revolving loans (collectively, the "Amended Credit Facility"),
subject to certain customary conditions including a borrowing base condition. In
addition, the Company has agreed to guarantee a $1.0 million loan that is
related to the long-term business agreement entered into at the time of the Hour
Eyes Acquisition. In connection with the Recapitalization, the amounts owed
under the Amended Credit Facility were paid in full and the facility canceled.
Simultaneously, the Company entered into a credit agreement (the "New Credit
Facility") which consists of (i) the $55.0 million term loan facility (the "Term
Loan Facility"); (ii) the $35.0 million revolving credit facility (the
"Revolving Credit Facility"); and (iii) the $100.0 million acquisition facility
(the "Acquisition Facility"), of which $50.0 million was committed at April 24,
1998. At January 2, 1999, the Company had $55.0 million in term loans
outstanding under the Term Loan Facility and $30.1 million outstanding under the
Acquisition Facility which funded the VisionWorld Acquisition. Approximately
$10.0 million of the Revolving Credit Facility is restricted for the repayment
of the capital lease obligation to Eckerd Corporation. Borrowings made under the
New Credit Facility bear interest at a rate equal to, at the Company's option,
LIBOR plus 2.25% or the Base Rate (as defined in the New Credit Facility) plus
1.25%. The Term Loan Facility matures five years from the closing date of the
New Credit Facility and will amortize quarterly in aggregate annual principal
amounts of approximately $0.0 million, $4.0 million, $12.0 million, $18.0
million, and $21.0 million, respectively, for years one through five after the
closing of the New Credit Facility on April 24, 1998.
Senior Notes. In 1993, the Company issued $70.0 million 12 percent senior
notes with detachable warrants to acquire common stock (the "Warrants"). The
senior notes and the Warrants were offered as Units (the "Units") consisting of
$1,000 principal amount of senior notes and one Warrant to acquire 0.4522 share
of common stock of the Company for no additional consideration. The fair value
of the Warrants at issuance was $600 and this value was recorded in
shareholders' equity/(deficit) with a corresponding discount from the face value
of the senior notes. This discount was accreted to interest expense using the
effective interest method over the life of the debt.
In June 1994, the senior notes discussed above were exchanged for $70.0
million of publicly registered 12% Senior Notes. The Senior Notes contained
substantially the same provisions as the senior notes issued described above.
In connection with the Recapitalization, the Company in-substance defeased
its previously issued 12% Senior Notes due 2003 by depositing with the trustee
for the Senior Notes (i) an irrevocable notice of redemption of the Senior Notes
on October 1, 1998 and (ii) United States government securities in an amount
necessary to yield on October 1, 1998 $78.4 million, which constitutes the
principal amount, premium and interest payable on the Senior Notes on the
October 1, 1998 redemption date. On October 1, 1998, the Senior Notes were
defeased as
F-19
64
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
scheduled and the Company recorded an extraordinary charge of $4.2 million on
the statement of operations for defeasance costs during the third quarter
related to the call premium on the bonds.
In connection with the Recapitalization, the Company completed a debt
offering of the Initial Notes, consisting of the Fixed Rate Notes and the
Floating Rate Notes. Interest on the Initial Notes will be payable semiannually
on each May 1 and November 1, commencing on November 1, 1998. Interest on the
Fixed Rate Notes accrues at the rate of 9 1/8% per annum. The Floating Rate
Notes bear interest at a rate per annum, reset semiannually, and equal to LIBOR
plus 3.98%. The Fixed Rate Notes and Floating Rate Notes will not be entitled to
the benefit of any mandatory sinking fund. As discussed in Note 9, on April 24,
1998, the Company entered into an interest rate swap agreement that converts a
portion of the Floating Rate Notes to a fixed rate.
The Company filed a registration statement with the Securities and Exchange
Commission with respect to an offer to exchange the Initial Notes for notes
which have terms substantially identical in all material respects to the Initial
Notes, except such notes are freely transferable by the holders thereof and are
issued without any covenant regarding registration (the "Exchange Notes"). The
registration statement was declared effective on January 28,1999. The exchange
period ended March 4, 1999. The Exchange Notes are the only notes of the
Company which are currently outstanding.
The Exchange Notes are senior uncollateralized obligations of the Company
and will rank pari passu with all other indebtedness of the Company that by its
terms other indebtedness is not subordinate to the Exchange Notes. In connection
with the issuance of the Exchange Notes, the Company incurred approximately
$11.2 million in debt issuance costs. These amounts are classified within other
assets in the accompanying balance sheets and are being amortized over the life
of the Exchange Notes. The unamortized amount of debt issuance costs as of
January 2, 1999 related to the Exchange Notes was $10.5 million.
The Exchange Notes contain various restrictive covenants which apply to
both the Company and the Guarantor Subsidiaries (defined herein), including
limitations on additional indebtedness, restriction on dividends and sale of
assets other than in the normal course of business. The New Credit Facility
contains additional restrictive covenants including a limitation on capital
requirements, minimum interest coverage, maximum leverage ratio, minimum net
worth and working capital requirements. As of January 2, 1999 the Company was in
compliance with the financial reporting covenants.
Capital Leases. In connection with the Visionworks Acquisition, the
Company assumed an agreement to sublease land, buildings and equipment at eight
operating locations. Under the terms of the agreement, the Company committed to
purchase such properties for $10.0 million and to pay Eckerd Corporation an
annual interest amount of $1.3 million. Additionally, in connection with the
VisionWorld Acquisition, the Company assumed agreements to sublease equipment
at the related operating locations. The Company has accounted for these
transactions as capital leases and has recorded the assets, as shown below, and
the future obligations on the balance sheet at $11.9 million.
F-20
65
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
January 3, January 2,
1998 1999
------------------- -------------------
Land $ 6,000 $ 6,000
Buildings and equipment 3,979 5,884
------------------- -------------------
$ 9,979 $ 11,884
=================== ===================
The Company's scheduled future minimum lease payments for the next five fiscal
years under the equipment capital lease are as follows:
1999 $ 713
2000 603
2001 570
2002 296
2003 --
Beyond 2003 --
-------------------
Total minimum lease payments 2,182
===================
Amounts representing interest 277
-------------------
Present value of minimum lease payments $ 1,905
===================
Long-term debt outstanding, including capital lease obligations, consists of the
following:
January 3, 1998 January 2, 1999
------------------- -------------------
Exchange Notes, face amount of $150,000, net of unamortized
debt discount of $461 $ -- $ 149,539
Senior Notes, face amount of $70,000, net of unamortized
debt discount of $370 69,630 --
New Credit Facility -- 85,100
Amended Credit Facility 42,645 --
Doctor notes 135 --
Capital lease obligations 9,979 11,884
------------------- -------------------
122,389 246,523
Less current portion (7,003) (3,578)
------------------- -------------------
$ 115,386 $ 242,945
=================== ===================
F-21
66
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Future principal maturities for long-term debt and capital lease obligations are
as follows:
1999 $ 3,578
2000 10,518
2001 24,536
2002 30,559
2003 22,785
Beyond 2003 154,547
------------------
Total future principal payments on debt $ 246,523
==================
As of the end of fiscal 1998, the fair value of the Company's Exchange
Notes was approximately $150.0 million. As of January 2, 1999, the fair value
of the capital lease obligations was approximately $11.9 million. These fair
values were estimated using quoted market prices and the present value of
estimated future cash flows. The carrying amount of the variable rate New Credit
Facility approximates its fair value.
9. INTEREST RATE SWAP
The Company does not hold or issue financial instruments for trading
purposes nor is it a party to leveraged derivatives. The Company uses interest
rate swaps that are "vanilla" and involve little complexity as hedge instruments
to manage interest rate risk.
The counter parties to the Company's derivatives consist of major
international financial institutions. Because of the number of these
institutions and their high credit ratings, management believes these
derivatives do not present significant credit risk to the Company.
Weighted Average
Notional Amounts Weighted Average Fixed Floating Receive
January 2, 1999 Maturity Date Pay Rate Rate
--------------------------- --------------------- ------------------------ ------------------------
$33.3 million 1999 5.9% 5.0%
$33.3 million 2000 5.9% 5.0%
$33.3 million 2001 5.9% 5.0%
Interest rate swap agreements effectively convert floating rates on
long-term debt to fixed rates. The Company's intent is to reduce overall
interest expense while maintaining an acceptable level of risk to interest rate
fluctuations. The swap agreements specifically hedge the Floating Rate Notes and
$50.0 million of the New Credit Facility. As market interest rates fluctuate,
the unrealized gain or loss on the swap portfolio moves in relationship to the
fair value of the underlying debt. The Company had an unrealized loss on the
interest rate swap portfolio of $1,247 as of January 2, 1999. The change in the
market value of these interest rate swaps is not recorded in the financial
position or operations of the Company. Interest to be paid or
F-22
67
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
received is accrued as an adjustment to interest expense. Upon termination of
interest rate swaps, the fair value of the swaps is recorded through operations.
If the hedged item is repaid early, the Company will evaluate if the swap
agreement is to be redesignated or exited.
10. CONDENSED CONSOLIDATING INFORMATION
The Exchange Notes described in Note 8 were issued by Eye Care Centers of
America, Inc. ("ECCA") and are guaranteed by Enclave Advancement Group, Inc.
("EAGI"), ECCA Managed Vision Care, Inc. ("MVC"), Visionworks Holdings, Inc.
("VHI") and Eye Care Holdings, Inc. ("Holdings') but are not guaranteed by
certain private optometrists ("OD"). The guarantor subsidiaries are wholly-owned
by the Company and the guarantees are full, unconditional and joint and several.
The following condensed consolidating financial information presents the
financial position, results of operations and cash flows of (i) ECCA, as parent,
as if it accounted for its subsidiaries on the equity method, (ii) EAGI, MVC,
VHI and Holdings (the "Guarantor Subsidiaries"), and (iii) OD. There were no
transactions between the Guarantor Subsidiaries during any of the periods
presented. Separate financial statements of the Guarantor Subsidiaries are not
presented herein as management does not believe that such statements would be
material to investors. Previous fiscal years are not presented herein as the
non-guarantor OD was consolidated starting in fiscal 1998 and prior to this date
all subsidiaries were guarantors.
F-23
68
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Consolidating Balance Sheet
January 2, 1999
Guarantor Consolidated
ASSETS Parent Subsidiaries OD Eliminations Company
--------- ------------ --------- ------------ ---------
Current assets:
Cash and cash equivalents $ 3,119 $ 2,008 $ -- $ -- $ 5,127
Accounts and notes receivable 83,553 17,165 64 (94,329) 6,453
Inventory 16,210 10,767 -- -- 26,977
Prepaid expenses and other 1,915 371 -- -- 2,286
Deferred income taxes 391 -- -- -- 391
--------- --------- --------- ---------- ---------
Total current assets 105,188 30,311 64 (94,329) 41,234
Property and equipment 38,780 29,338 -- -- 68,118
Intangibles 19,488 82,872 99 -- 102,459
Other assets 10,606 490 -- -- 11,096
Investment in subsidiaries 6,235 -- -- (6,235) --
--------- --------- --------- ---------- ---------
$ 180,297 $ 143,011 $ 163 $ (100,564) $ 222,907
========= ========= ========= ========== =========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 27,711 $ 87,539 $ -- $ (94,329) $ 20,921
Current portion of long-term debt 3,000 578 -- -- 3,578
Deferred revenue 3,497 1,834 -- -- 5,331
Accrued payroll expense 1,415 1,373 -- -- 2,788
Accrued interest 2,953 394 -- -- 3,347
Other accrued expenses 5,345 2,841 -- -- 8,186
--------- --------- --------- ---------- ---------
Total current liabilities 43,921 94,559 -- (94,329) 44,151
Deferred income taxes 391 -- -- -- 391
Long-term debt, less current maturities 201,539 41,306 100 -- 242,945
Deferred rent 2,272 974 -- -- 3,246
Deferred gain 2,175 -- -- -- 2,175
--------- --------- --------- ---------- ---------
Total liabilities 250,298 136,839 100 (94,329) 292,908
--------- --------- --------- ---------- ---------
Shareholders' equity/(deficit):
Common stock 75 -- -- -- 75
Preferred stock 32,793 -- -- -- 32,793
Additional paid-in capital 60,958 -- -- -- 60,958
Accumulated deficit (163,827) 6,172 63 (6,235) (163,827)
--------- --------- --------- ---------- ---------
Total shareholders' equity/(deficit) (70,001) 6,172 63 (6,235) (70,001)
--------- --------- --------- ---------- ---------
$ 180,297 $ 143,011 $ 163 $ (100,564) $ 222,907
========= ========= ========= ========== =========
Consolidating Income Statement
For the Year Ended January 2, 1999
Guarantor Consolidated
Parent Subsidiaries OD Eliminations Company
--------- ------------ --------- ------------ ------------
Optical sales $ 147,973 $ 79,545 $ 7,718 $ -- $ 235,236
Management fees 1,438 2,615 -- (1,438) 2,615
Investment earnings in subsidiaries 2,398 -- -- (2,398)
--------- --------- --------- --------- ---------
Net revenues 151,809 82,160 7,718 (3,836) 237,851
Operating costs and expenses:
Cost of goods sold 49,314 29,552 1,770 -- 80,636
Selling, general and administrative expenses 83,388 44,558 5,882 (1,438) 132,390
Recapitalization and other expenses 25,819 (16) -- -- 25,803
Amortization of intangibles:
Goodwill 994 2,557 1 -- 3,552
Noncompete and other intangibles -- 153 -- -- 153
--------- --------- --------- --------- ---------
Total operating costs and expenses 159,515 76,804 7,653 (1,438) 242,534
--------- --------- --------- --------- ---------
Income (loss) from operations (7,706) 5,356 65 (2,398) (4,683)
Interest expense, net 16,058 3,099 2 -- 19,159
In-substance defeased bonds
interest expense, net 2,418 -- -- -- 2,418
--------- --------- --------- --------- ---------
Income (loss) before income taxes (26,182) 2,257 63 (2,398) (26,260)
Income tax expense 91 (78) -- -- 13
--------- --------- --------- --------- ---------
Net income (loss) before extraordinary item (26,273) 2,335 63 (2,398) (26,273)
Extraordinary loss on early extinguishment of
long-term debt 8,355 -- -- -- 8,355
--------- --------- --------- --------- ---------
Net income (loss) $ (34,628) $ 2,335 $ 63 $ (2,398) $ (34,628)
========= ========= ========= ========= =========
F-24
69
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Consolidating Statement of Cash Flows
For the Year Ended January 2, 1999
Guarantor Consolidated
Parent Subsidiaries OD Eliminations Company
--------- ------------ --------- ------------ ------------
Cash flows from operating activities:
Net income (loss) $ (34,628) $ 2,335 $ 63 $ (2,398) $ (34,628)
Adjustments to reconcile net income (loss) to net
Cash provided by operating activities:
Depreciation 8,656 3,689 -- -- 12,345
Amortization of intangibles 993 2,711 1 -- 3,705
Other Amortization 1,415 163 -- -- 1,578
Amortization of deferred gain (159) -- -- -- (159)
Deferred revenue 494 160 -- -- 654
Deferred rent 99 105 -- -- 204
Other (1,511) 996 -- -- (515)
(Gain) loss on disposition of property and
equipment 775 (142) -- -- 633
Extraordinary loss on early extinguishment of
long-term debt 8,355 -- -- -- 8,355
Changes in operating assets and liabilities:
Accounts and notes receivable (62,032) (12,959) (64) 74,866 (189)
Inventory 669 (601) -- -- 68
Prepaid expenses and other 661 507 -- -- 1,168
Accounts payable and accrued liabilities 21,005 60,835 -- (74,866) 6,974
--------- --------- --------- --------- ---------
Net cash provided by (used in) operating activities (55,208) 57,799 -- (2,398) 193
--------- --------- --------- --------- ---------
Cash flows from investing activities:
Acquisition of property and equipment (16,923) (3,733) -- -- (20,656)
Proceeds from sale of property and equipment 1,011 185 -- -- 1,196
Payment received on notes receivable 2 175 -- -- 177
Net outflow for The Visionworld Acquisition -- (32,942) (100) -- (33,042)
Purchase of investment securities-restricted (76,618) -- -- -- (76,618)
Maturity of investment securities-restricted 78,400 -- -- -- 78,400
Investment in Subsidiaries (2,398) -- -- 2,398 --
Reclass Mexico Retained Earning to Parent (1,997) 1,997 -- -- --
--------- --------- --------- --------- ---------
Net cash provided by (used in) investing activities (18,523) (34,318) (100) 2,398 (50,543)
--------- --------- --------- --------- ---------
Cash flows from financing activities:
Proceeds from issuance of long-term debt 204,511 30,000 100 -- 234,611
Proceeds from the issuance of common stock 71,140 -- -- -- 71,140
Proceeds from issuance of preferred stock 27,750 -- -- -- 27,750
Payments related to debt issuance (11,153) -- -- -- (11,153)
Payments to retire mandatorily redeemable
preferred stock -- (12,385) -- -- (12,385)
Redemption of common stock (130,775) 1,385 -- -- (129,390)
Recapitalization fees (12,733) -- -- -- (12,733)
Payments on debt and capital leases (70,000) (42,917) -- -- (112,917)
Payment of call premium (4,200) -- -- -- (4,200)
Payment of in-substance defeased bonds
interest expense, net (2,418) -- -- -- (2,418)
--------- --------- --------- --------- ---------
Net cash provided by (used in) financing activities 72,122 (23,917) 100 -- 48,305
--------- --------- --------- --------- ---------
Net decrease in cash and cash equivalents (1,609) (436) -- -- (2,045)
Cash and cash equivalents at beginning of period 4,728 2,444 -- -- 7,172
--------- --------- --------- --------- ---------
Cash and cash equivalents at end of period $ 3,119 $ 2,008 $ -- $ -- $ 5,127
========= ========= ========= ========= =========
F-25
70
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
11. PREFERRED STOCK
During 1996, the Company issued 110,000 shares of Series A Cumulative
Mandatorily Redeemable Exchangeable Pay-in-Kind Preferred Stock ("Preferred
Stock"). In conjunction with the Recapitalization, the Company repurchased the
Preferred Stock, canceled it and issued 300,000 shares of New Preferred Stock,
par value $ .01 per share. Dividends on shares of New Preferred Stock are
cumulative from the date of issue (whether or not declared) and will be payable
when and as may be declared from time to time by the Board of Directors of the
Company. Such dividends accrue on a daily basis from the original date of issue
at an annual rate per share equal to 13% of the original purchase price per
share, with such amount to be compounded quarterly. The New Preferred Stock will
be redeemable at the option of the Company, in whole or in part, at $100 per
share plus (i) the per share dividend rate and (ii) all accumulated and unpaid
dividends, if any, to the date of redemption, upon occurrence of an offering of
equity securities, a change of control or certain sales of assets.
12. SHAREHOLDERS' EQUITY
Warrants. As discussed in Note 8, the Senior Notes were issued with
detachable warrants entitling the holder to acquire, for no additional
consideration, 0.4522 shares of common stock. In conjunction with the
Recapitalization and the repayment of the Senior Notes, the warrants were
issued.
Senior Officers' Stock Options. In 1993, the Company entered into
employment agreements with certain senior officers (the "Senior Officers"). In
connection with these employment agreements, each Senior Officer also entered
into a non-qualified stock option agreement whereby each Senior Officer was
granted stock options to purchase common stock of the Company at $31.00 per
share. Certain of these options vested at issuance while others vest over
time or upon the Company reaching certain profitability levels for fiscal years
1995 through 1998. In connection with the Recapitalization, the outstanding
options were simultaneously vested and exercised on April 24, 1998.
Following is a summary of activity in the plan for fiscal years 1996, 1997
and 1998 and does not reflect the 12 for 1 stock split on April 24, 1998.
F-26
71
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Avg. Option
Price Options Options
Per Share($) Outstanding Exercisable
---------------- ------------------ ------------------
Outstanding - December 30, 1995 100,808 22,159
Granted 31.00 75,000 --
Became Exercisable 31.00 -- 14,748
Canceled or expired 31.00 (100,808) (26,907)
------------------ ------------------
Outstanding - December 28, 1996 75,000 10,000
Granted 31.00 -- --
Became Exercisable 31.00 -- 28,333
Canceled or expired -- --
------------------ ------------------
Outstanding - January 3, 1998 75,000 38,333
Granted 31.00 -- --
Became Exercisable 31.00 -- 36,667
Exercised 31.00 (75,000) (75,000)
------------------ ------------------
Outstanding - January 2, 1999 -- --
================== ==================
1993 Executive Stock Option Plan. In 1993, the Company authorized a
non-qualified stock option plan whereby key executives (other than the Senior
Officers) may be offered options to purchase the Company's common stock. Under
the plan, the exercise price set by the Board of Directors of the Company must
at least equal the fair market value of the Company's common stock at the date
of grant. The options vest in four equal annual installments provided the
optionee is an employee of the Company on the anniversary date and shall expire
10 years after the date of grant. In connection with the Recapitalization, the
outstanding options were simultaneously vested and exercised on April 24, 1998.
F-27
72
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Following is a summary of activity in the plan for the years 1996, 1997 and 1998
and does not reflect the 12 for 1 stock split on April 24, 1998.
Avg. Option
Price Options Options
Per Share($) Outstanding Exercisable
----------------- ---------------- -----------------
Outstanding - December 30, 1995 31,813 4,655
Granted -- --
Became exercisable 31.00 -- 6,461
Canceled or expired 31.00 (13,168) (3,438)
---------------- -----------------
Outstanding - December 28, 1996 18,645 7,678
Granted -- --
Became exercisable 31.00 -- 8,584
Canceled or expired -- --
---------------- -----------------
Outstanding - January 3, 1998 18,645 16,262
Granted -- --
Became exercisable 31.00 -- 2,383
Exercised 31.00 (18,645) (18,645)
---------------- -----------------
Outstanding - January 2, 1999 -- --
================ =================
1996 Executive Stock Option Plan. On September 5, 1996, the Company
authorized a non-qualified stock option plan whereby key executives (other than
the Senior Officers) may be offered options to purchase the Company's common
stock. Under the plan, the exercise price set by the Board of Directors of the
Company must at least equal the fair market value of the Company's common stock
at the date of grant. The options begin vesting one year after the date of grant
in four installments of 10%, 15%, 25% and 50% provided the optionee is an
employee of the Company on the anniversary date and shall expire 10 years after
the date of grant. Under certain specified conditions the vesting schedule may
be altered. During 1996, the Company granted options to purchase 91,000 shares
under this plan at an option price of $31 to $65 per share. During 1997, the
Company granted options to purchase 26,000 shares under this plan. In connection
with the Recapitalization, the outstanding options were simultaneously vested
and exercised on April 24, 1998.
F-28
73
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Following is a summary of activity in the plan for the years 1996, 1997 and 1998
and does not reflect the 12 for 1 stock split on April 24, 1998.
Avg. Option Price Options Options
Per Share($) Outstanding Exercisable
------------------------- -------------------- -------------------
Outstanding - December 30, 1995 -- --
Granted 31.00 to 65.00 91,000 --
Became exercisable -- --
Canceled or expired -- --
-------------------- -------------------
Outstanding - December 28, 1996 91,000 --
Granted 70.00 to 105.00 26,000 --
Became exercisable 31.00 to 65.00 -- 6,450
Canceled or expired 31.00 (7,500) (200)
-------------------- -------------------
Outstanding - January 3, 1998 109,500 6,250
Granted 70.00 to 105.00 -- --
Became exercisable 31.00 to 65.00 -- 103,250
Exercised 31.00 to 105.00 (109,500) (109,500)
-------------------- -------------------
Outstanding - January 2, 1999 -- --
==================== ===================
1998 Executive Stock Option Plan. On April 25, 1998, the Company authorized
a non-qualified stock option plan whereby key executives and senior officers may
be offered options to purchase the Company's Common Stock. Under the plan, the
exercise price set by the Board of Directors of the Company must at least equal
the fair market value of the Company's Common Stock at the date of grant. The
options begin vesting one year after the date of grant in four installments of
10%, 15%, 25% and 50% provided the optionee is an employee of the Company on the
anniversary date and shall expire 10 years after the date of grant. Under
certain specified conditions the vesting schedule may be altered. During 1998,
the Company granted options to purchase 482,000 shares under this plan at an
option price of $10.41 per share. Following is a summary of activity in the plan
for fiscal 1998.
Avg. Option Price Options Options
Per Share($) Outstanding Exercisable
--------------------- ----------------- ------------------
Outstanding - January 3, 1998 -- --
Granted 10.41 482,000 --
Became exercisable -- --
Canceled or expired 10.41 (12,500) --
----------------- ------------------
Outstanding - January 2, 1999 469,500 --
================= ==================
F-29
74
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Other Stock Options and Warrants. In November 1993, the Company granted
stock options to two directors to purchase 3,000 and 6,000 shares, respectively,
of the Company's common stock. Each option is exercisable at $31.00 per share to
be vested in equal installments on December 31, of each of 1994, 1995, and 1996
with such options expiring 10 years from the date of grant. Additionally, in
December 1995 the Company granted stock options to a director to purchase 4,000
shares of the Company's common stock. The option is exercisable at $31.00 per
share to vest upon the date of grant and expire 10 years from the date of grant.
In December 1996, the Company granted stock options to three directors to
purchase shares of the Company's common stock. Each option vests in four equal
installments starting on December 5, 1997 and expires ten years from the date of
grant. One director was granted stock options of 5,000, 4,000 and 4,000 shares
exercisable at $70, $90 and $110 per share, respectively. Another director was
granted 1,000 shares at $70 per share. A third director was granted 1,000 and
3,000 shares at $70 and $65 per share, respectively. Also, the third director
was granted 3,000 shares at $70 per share. In connection with the
Recapitalization, all 29,226 outstanding options under the plan were
simultaneously vested and exercised on April 24, 1998.
Subsequent to the Recapitalization, two directors were granted options to
purchase 5,000 and 111,412 shares, respectively. Each option is exercisable at
$10.41 per share and begin vesting one year after the date of grant in four
installments of 10%, 15%, 25%, and 50% with such options expiring 10 years from
the date of grant. Similarly, the Company's chief executive officer was granted
options to purchase 371,376 shares. Each option is exercisable at $10.41 per
share and subject to a vesting schedule which will be one-half time based and
one-half performance based.
In November 1993, the Company granted a warrant to a foreign bank to
purchase a total of 3,000 shares of the Company's common stock. In connection
with the Recapitalization, the warrant was exercised on April 24, 1998.
The Company has elected to follow Accounting Principles Board Opinion No.
25 "Accounting for Stock Issued to Employees" ("APB 25") and related
interpretations in accounting for its employee stock options because, as
discussed below, the alternative fair value accounting provided for under FASB
Statement No. 123 "Accounting for Stock-Based Compensation," requires use of
option valuation models that were not developed for use in valuing employee
stock options of privately held companies. Under APB 25, because the exercise
price of the Company's employee stock options equals the estimated fair value of
the underlying stock on the date of grant, no compensation expense is
recognized.
Pro forma information regarding net income and earnings per share is
required by FASB Statement No. 123, which also requires that the information be
determined as if the Company has accounted for its employee stock options
granted subsequent to December 31, 1994 under the fair value method of that
Statement. The fair value for these options was estimated at the date of the
grant using the minimum value method with the following assumptions for 1996,
1997 and 1998, respectively: risk-free interest rates of 6%; no dividend yield;
and a weighted-average expected life of the options of 4 years.
F-30
75
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Option valuation models require the input of highly subjective assumptions.
Because the Company's employee stock options have characteristics significantly
different from those of traded options, and because changes in the subjective
input assumptions can materially affect the fair value estimate, in management's
opinion, the existing models do not necessarily provide a reliable single
measure of the fair value of its employee stock options.
For purposes of pro forma disclosures, the estimated fair value of the
options is amortized to expense over the options' vesting period. The Company's
pro forma net income for fiscal year 1997 and 1998 are as follows:
FISCAL FISCAL
1997 1998
----------------------- ---------------------------------
Pro forma Net Income/(Loss) $ 4,802 $ (34,735)
The pro forma calculations include only the effects of 1995 through 1998 grants.
As such, the impacts are not necessarily indicative of the effects on reported
net income of future years.
Deferred Stock Plan. Effective January 1, 1994, the Company adopted a
Deferred Stock Plan whereby certain directors, executives or employees of the
Company (as approved by the Board of Directors) may elect to defer part of their
compensation to be used to purchase common stock of the Company at fair market
value to be determined in advance by the Board of Directors. At April 24, 1998,
all 17,291 issuable shares in the plan were issued in connection with the
Recapitalization.
F-31
76
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
13. INCOME TAXES
The provision for income taxes is comprised of the following:
Year Ended
---------------------------------------------------------------
December 28, January 3, January 2,
1996 1998 1999
------------------ ------------------- -------------------
Current $ 188 $ 335 $ 13
Deferred -- -- --
------------------ ------------------- -------------------
$ 188 $ 335 $ 13
================== =================== ===================
For the years ended December 28, 1996, January 3, 1998 and January 2, 1999 there
was approximately $188, $335 and $13 of federal income tax expense.
The reconciliation between the federal statutory tax rate at 34% and the
Company's effective tax rate is as follows:
January 3, January 2,
1998 1999
------------------ ------------------
Expected tax expense (benefit) $ 1,887 $ (11,769)
Goodwill 872 1,079
Deferred rent 142 142
Investment in foreign subsidiary 45 -
Nondeductible meals and donations 29 26
Change in valuation allowance (2,924) 9,938
Other 284 597
------------------ ------------------
$ 335 $ 13
================== ==================
The components of the net deferred tax assets are as follows:
January 3, January 2,
1998 1999
------------------- -------------------
Total deferred tax liabilities, current $ (55) $ (37)
Total deferred tax liabilities, long-term (329) (354)
Total deferred tax assets, current 2,458 3,274
Total deferred tax assets, long-term 4,817 13,944
Valuation allowance (6,889) (16,827)
------------------- -------------------
Net deferred tax assets $ 2 $ --
=================== ===================
F-32
77
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
The sources of the difference between the financial accounting and tax
basis of the Company's assets and liabilities which give rise to the deferred
tax assets and deferred tax liabilities are as follows:
January 3, January 2,
1998 1999
-------------- ----------------
Deferred tax assets:
Deferred rent $ 743 $ 678
Deferred compensation 9 --
Deferred revenue 1,055 1,402
Net operating loss and credit carryforwards 2,057 9,535
Noncompete and SearsCard
agreements $31 --
Inventory basis differences 453 590
Accrued salaries 198 433
Property and equipment 2,729 4,409
Other - 171
-------------- ----------------
Total deferred tax assets 7,275 17,218
Valuation allowance (6,889) (16,827)
-------------- ----------------
Net deferred tax assets $ 386 $ 391
============== ================
Deferred tax liabilities:
Store preopening costs $ 53 $ 135
Deferred financing costs 76 --
Accounts receivable 37 102
Other 218 154
-------------- ----------------
Net deferred tax liability $ 384 $ 391
============== ================
At January 2, 1999 and January 3, 1998, the Company had, subject to the
limitations discussed below, net operating loss carryforwards for tax purposes
of $28,044 and $4,513, respectively. These loss carryforwards will expire from
2000 through 2013 if not utilized.
During September 1996, the Company consummated the Visionworks Acquisition.
As a result of the limitations imposed by Section 382, the use of net operating
loss carryforwards of $6,288 acquired in the acquisition are limited to
approximately $3,567 per year.
In addition to the Section 382 limitations, uncertainties exist as to the
future realization of the deferred tax asset under the criteria set forth under
FASB Statement No. 109. Therefore, the Company has established a valuation
allowance for deferred tax assets of $16,827 at January 2, 1999 and $6,889 at
January 3, 1998.
F-33
78
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
14. EMPLOYEE BENEFITS
401 (K) Plan. The Company maintains a defined contribution plan whereby
substantially all employees who have been employed for at least six consecutive
months are eligible to participate. Contributions are made by the Company as a
percentage of employee contributions. In addition, discretionary contributions
may be made at the direction of the Company's Board of Directors. Total Company
contributions were approximately $97, $163 and $127 for fiscal 1996, 1997 and
1998 respectively.
15. LEASES
The Company is obligated as lessee under operating leases for substantially
all of the Company's retail facilities as well as certain warehouse space. In
addition to rental payments, the leases generally provide for payment by the
Company of property taxes, insurance, maintenance and its pro rata share of
common area maintenance. These leases range in terms of up to 15 years. Certain
leases also provide for additional rent in excess of the base rentals calculated
as a percentage of sales.
The Company subleases a portion of substantially all of the stores to an
independent optometrist or a corporation controlled by an independent
optometrist. The terms of these leases or subleases are principally one to
fifteen years with rentals consisting of a percentage of gross receipts, base
rentals, or a combination of both. Certain of these leases contain renewal
options.
Certain of the Company's lease agreements contain provisions for scheduled
rent increases or provide for occupancy periods during which no rent payment is
required. For financial statement purposes, rent expense is recorded based on
the total rentals due over the entire lease term and charged to rent expense on
a straight-line basis. The difference between the actual cash rentals paid and
rent expenses recorded for financial statement purposes is recorded as a
deferred rent obligation. At the end of fiscal years 1997 and 1998, deferred
rent obligations aggregated approximately $3.0 million and $3.2 million,
respectively.
In December 1993, the Company purchased its headquarters facilities
location, which was previously leased under an operating lease. During 1997, the
Company sold this location for net proceeds of $4.8 million. The Company entered
into a 15 year operating lease with the new owners and will maintain its
corporate headquarters at its current location. As a result of this transaction,
the Company recorded a deferred gain, which will be amortized over the life of
the lease. In addition, the Company continues to sublease office space on terms
that range from one to four years within the headquarters facility.
F-34
79
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
Rent expense for all locations, net of lease and sublease income, is as
follows. For the purposes of this table, base rent expense includes common area
maintenance costs. Common area maintenance costs were approximately 25, 22 and
21 percent of base rent expense for fiscal years 1996, 1997 and 1998.
------------------ --------------- ----------------
December 28, January 3, January 2,
1996 1998 1999
------------------ --------------- ----------------
Base rent expense $ 17,547 $ 24,007 $ 26,204
Rent as a percent of sales 80 186 151
Lease and sublease income (2,280) (4,338) (4,211)
------------------ --------------- ----------------
Rent expense, net $ 15,347 $ 19,855 $ 22,144
================== =============== ================
Future minimum lease payments, excluding common area maintenance costs, net
of future minimum lease and sublease income under noncancelable operating leases
for the next five years and beyond are as follows:
Operating Lease and Operating
Rental Sublease Lease
Payments Income Net
--------------- ------------ --------------
1999 $ 21,811 $ 1,820 $ 19,991
2000 20,250 1,704 18,546
2001 17,904 1,488 16,416
2002 15,553 1,251 14,302
2003 13,025 1,017 12,008
Beyond 2003 47,564 1,839 45,725
--------------- ------------ --------------
Total minimum lease payments $ 136,107 $ 9,119 $ 126,988
=============== ============ ==============
F-35
80
EYE CARE CENTERS OF AMERICA, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLAR AMOUNTS IN THOUSANDS UNLESS INDICATED OTHERWISE)
16. COMMITMENTS AND CONTINGENCIES
The Company is involved in various claims and legal actions arising in the
ordinary course of business. In the opinion of management, the ultimate
disposition of these matters will not have a material adverse effect on the
Company's consolidated financial position or consolidated results of operations.
F-36
81
SCHEDULE II
EYE CARE CENTERS OF AMERICA, INC.
CONSOLIDATED VALUATION AND QUALIFYING ACCOUNTS
CHARGE TO/ CHARGE TO/
BALANCE AT CREDITED FROM CREDITED FROM DEDUCTIONS BALANCE
BEGINNING COSTS AND OTHER FROM AT CLOSE
OF PERIOD EXPENSES ACCOUNTS RESERVE OF PERIOD
----------- ------------- ------------- ----------- -----------
Allowance for doubtful accounts of
current receivables:
Year Ended December 28, 1996 ............. 130,000 -- 121,000 -- 251,000
Year Ended January 3, 1998 ............... 251,100 -- 67,000 -- 318,000
Year Ended January 2, 1999 ............... 318,000 -- 243,000 -- 561,000
Inventory obsolescence reserves:
Year Ended December 28, 1996 ............. 361,000 -- 200,000 -- 561,000
Year Ended January 3, 1998 ............... 561,000 -- -- -- 561,000
Year Ended January 2, 1999 ............... 561,000 (9,000) 300,000 -- 852,000
F-37
82
INDEX TO EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
- ------- -----------
2.1 Stock Purchase Agreement dated August 15, 1996 by and between Eye Care Centers of America, Inc., Visionworks
Holdings, Inc. and the Sellers listed therein. (a)
2.2 Stock Purchase Agreement, dated September 30 1997, by and among Eye Care Centers of America, Inc., a Texas
corporation, Robert A. Samit, O. D. and Michael Davidson, O. D. (a)
2.3 Recapitalization Agreement dated as of March 6, 1998 among ECCA Merger Corp., Eye Care Centers of America, Inc.
and the sellers Listed therein. (a)
2.4 Amendment No. 1 to the Recapitalization Agreement dated as of April 23, 1998 among ECCA Merger Corp., Eye Care
Centers of America, Inc, and the sellers listed therein. (a)
2.5 Amendment No. 2 to the Recapitalization Agreement dated as of April 24, 1998 among ECCA Merger Corp., Eye Care
Centers of America, Inc. and the sellers listed therein. (a)
2.6 Articles of Merger of ECCA Merger Corp. with and into Eye Care Centers of America, Inc. dated April 24, 1998.
(a)
2.7 Master Asset Purchase Agreement, dated as of August 22, 1998, by and among Eye Care Centers of America, Inc.,
Mark E. Lynn, Dr. Mark Lynn & Associates, PLLC; Dr. Bizer's Vision World, PLLC and its affiliates. (a)
2.8 Letter Agreement, dated October 1, 1998, amending and modifying that certain Master Asset Purchase Agreement,
dated as of August 22, 1998, by and among Eye Care Centers of America, Inc.; Mark E. Lynn; Dr. Mark Lynn &
Associates, PLLC; Dr. Bizer's VisionWorld, PLLC and its affiliates. (a)
83
3.1 Restated Articles of Incorporation of Eye Care Centers of America Inc. (a)
3.2 Statement of Resolution of the Board of Directors of Eye Care Centers of America, Inc. designating a series of
Preferred Stock. (a)
3.3 Amended and Restated By-laws of Eye Care Centers of America, Inc. (a)
4.1 Indenture dated as of April 24, 1998 among Eye Care Centers of America, Inc., the Guarantors named therein and
United States Trust Company of New York, as Trustee for the 9 1/8% Senior Subordinated Notes Due 2008 and
Floating Interest Rate Subordinated Term Securities. (a)
4.2 Form of Fixed Rate Exchange Note (included in Exhibit 4.1 Hereto). (a)
4.3 Form of Floating Rate Exchange Note (included in Exhibit 4.1 Hereto). (a)
4.4 Form of Guarantee (included in Exhibit 4.1 hereto). (a)
4.5 Registration Rights Agreement dated April 24, 1998 between Eye Care Centers of America, Inc., the subsidiaries
of the Company named as guarantors therein, BT Alex. Brown Incorporated and Merrill Lynch, Pierce, Fenner &
Smith Incorporated. (a)
10.1 Form of Stockholders' Agreement dated as of April 24, 1998 by and among Eye Care of America, Inc. and the
shareholders listed therein. (a)
10.2 1998 Stock Option Plan. (a)
10.3 Amended and Restated Deferred Stock Plan of Eye Care Centers of America, Inc. (a)
10.4 Employment Agreement dated April 24, 1998 by and between Eye Care Centers of America, Inc. and Bernard W.
Andrews. (a)
10.5 Stock Option Agreement dated April 24, 1998 by and between Bernard W. Andrews and Eye Care Centers of America,
Inc. (a)
10.6 Form of Employment Agreement dated January 1, 1998 between Eye Care Centers of America, Inc. and Mark T.
Pearson, William A. Shertzer, Jr., George Gebhardt and Kent M. Keish. (a)
10.7 Employment Agreement dated March 24, 1997 between Eye Care Centers of America, Inc. and Michele Benoit. (a)
84
10.8 Management Agreement, dated as of April 24, 1998, by and between Thomas H. Lee Company and Eye Care Centers of
America, Inc. (a)
10.9 Retail Business Management Agreement, dated September 30, 1997, by and between Dr. Samit's Hour Eyes
Optometrist, P.C., a Virginia professional corporation, and Visionary Retail Management, Inc., a Delaware
corporation. + (a)
10.10 Professional Business Management Agreement dated September 30, 1997, by and between Dr. Samit's Hour Eyes
Optometrists, P.C., a Virginia professional corporation, and Visionary MSO, Inc., a Delaware corporation. + (a)
10.11 Contract for Purchase and Sale dated May 29, 1997 by and between Eye Care Centers of America, Inc. and JDB Real
Properties, Inc. (a)
10.11 Contract for Purchase and Sale dated May 29, 1997 by and between Eye Care Centers of America, Inc. and JDB Real
Properties, Inc. (a)
10.12 Amendment to Contract for Purchase and Sale dated July 3, 1997 by and between Eye Care Centers of America, Inc.
and JDB Real Properties, Inc. (a)
10.13 Second Amendment to Contract for Purchase and Sale dated July 10, 1997 by and between Eye Care Centers of
America, Inc. and JDB Real Properties, Inc. (a)
10.14 Third Amendment to Contract for Purchase and Sale by and between Eye Care Centers of America, Inc., John D.
Byram, Dallas Mini #262. Ltd. and Dallas Mini #343, Ltd. (a)
10.15 Commercial Lease Agreement dated August 19, 1997 by and between John D. Byram, Dallas Mini #262, Ltd. and Dallas
Mini #343, Ltd. And Eye Care Centers of America, Inc. (a)
10.16 1997 Incentive Plan for Key Management. (a)
10.17 1998 Incentive Plan for Key Management. (a)
10.18 Employment Agreement and Noncompetition Agreement, dated December 31, 1996 by and between Eye Care Centers of
America, Inc. and Gary D. Hahs, together with letter, dated November 21, 1997, regarding extension of term. (a)
10.19 Master Lease Agreement, dated August 12, 1997, by and between Pacific Financial Company and Eye Care Centers of
America, Inc., together with all amendments, riders and schedules thereto. (a)
10.20 Credit Agreement, dated as of April 23, 1998, among Eye Care Centers of America, Inc., Various Lenders, Bankers
Trust Company, as Administrative Agent, and Merrill Lynch Capital Corporation, as Syndication Agent. (a)
10.21 Purchase Agreement, dated as of April 24, 1998, by and among Eye Care Centers of America, Inc., the subsidiaries
of Eye Care Centers of America, Inc. named therein, BT Alex. Brown Incorporated and Merrill Lynch, Pierce,
Fenner & Smith Incorporated. (a)
10.22 Secured Promissory Note, dated April 24, 1998, issued by Bernard W. Andrews in favor of Eye Care Centers of
America, Inc. (a)
85
10.23 Form of Eye Care Centers of America, Inc. standard managed care contract. (a)
10.24 Employment Agreement, dated July 8, 1998, by and between Eye Care Centers of America, Inc. and David E. McComas.
(a)
10.25 Employment Agreement, dated November 2, 1998, by and between Eye Care Centers of America, Inc. and Alan E.
Wiley. (a)
10.26 Retail Business Management Agreement, dated October 1, 1998, by and between Visionary Retail Management, Inc., a
Delaware corporation, and Dr. Mark Lynn & Associates, PLLC, a Kentucky professional limited liability company.+
(b)
10.27 Professional Business Management Agreement, dated October 1, 1998, by and between Visionary MSO, Inc., a
Delaware Corporation, and Dr. Mark Lynn & Associates, PLLC, a Kentucky professional limited liability company.+
(b)
12.1 Statement re Computation of Ratios (b)
21.1 List of subsidiaries of Eye Care Centers of America, Inc. (b)
24.1 Powers of Attorney (contained on the signature pages to this report). (b)
27.1 Financial Data Schedule. (b)
- ----------
+ Portions of this Exhibit have been omitted pursuant to an
application for an order declaring confidential treatment filed
with the Securities and Exchange Commission.
(a) Incorporated by reference from the Registration Statement on Form
S-4 (File No. 333 - 56551).
(b) Filed herewith.